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ABSTRACT 
 
Carbon nanotubes (CNTs) are attractive candidates for the development of 
scaffolds for neural regeneration thanks to their ability to conduct electrical 
stimuli, to interface with cells and to mimic the neural environment. This thesis 
work concerns the development of a freestanding nanocomposite scaffold 
composed of multi-walled CNTs in a poly-L-lactic (PLLA) matrix that combines the 
conductive, mechanical and topographical features of CNTs with the 
biocompatibility of PLLA. Such CNT-PLLA scaffold resulted to support growth and 
differentiation of neuronal SH-SY5Y cells better than PLLA alone. In order to 
mimic guidance cues from the neural environment, biomimetic peptides were 
designed to reproduce regulatory motifs from L1CAM and LINGO1 proteins, that 
are involved in neurite outgrowth control. Both peptides - which neither alter 
cell proliferation nor induce cell death - could specifically and positively 
modulate neuronal differentiation when either used to coat well bottoms or 
added to the culture medium (with highest efficiency at 1 M concentration). 
Furthermore, cell differentiation resulted to be synergistically improved by the 
combination of the nanocomposite scaffold and the peptides, thus suggesting a 
prototype for the development of implants for long-term neuronal growth and 
differentiation. 
Then, the CNT-PLLA matrix was electrospun into fibres of submicrometric size in 
order to better mimic the neural environment, i.e. neuronal processes and 
collagenous components of the extracellular matrix. These scaffolds were shown 
to be biocompatible and to promote the formation of new neurites that extend 
along the scaffold fibres. Since cells are influenced by the scaffold topography, 
the orientation of the scaffold fibres opens up the perspective to promote a 
polarized neurite outgrowth. Moreover, the neuritogenic properties of the 
scaffolds are further enhanced when LINGO1 derivative peptide is added to 
culture medium; this represents a good starting point for developing next 
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generation scaffolds upon peptide functionalization. Moreover, human 
circulating multipotent cells (hCMCs) were grown onto the scaffolds and treated 
with peptides in order to asses if this autologous and accessible source of stem 
cells is capable of neuronal differentiation thanks to the scaffold and peptide 
characteristics. The CNT-PLLA scaffolds and its respective electrospun version 
resulted to be suitable for hCMCs adhesion and growth, showing a very good 
level of biocompatibility, and the hCMCs growing onto the scaffolds showed 
typical features of cells from the neuronal lineage, such as long neuritic 
protrusions that are tipped with fan-shaped structures resembling growth cones. 
Moreover, soon after cell seeding, the scaffolds were shown to promote the 
upregulation of markers typical of the neuronal lineage.The biomimetic peptides 
were also shown to influence cell morphology and to upregulate neuronal 
markers. These results suggest that hCMCs can acquire neuronal commitment 
thanks to scaffold/peptide properties per se, i.e. even in the absence of those 
typical growth factors that are normally used to promote the neuronal 
differentiation of stem cells. Further improvements in the scaffold geometry and 
composition, functionalization with peptides and culture conditions are 
necessary to achieve the complete neuronal differentiation of cells and to 
control the neuron subtype obtained, but our system resulted to be a good 
starting point for setting up implantable scaffolds for autologous neuronal 
differentiation. Future functional assessment of synaptic transmission and 
electrophysiological properties of cells onto the scaffolds will be of great interest. 
Moreover, coupling such scaffolds with electrical stimulation (which is readily 
achievable using CNT based materials) can boost further analyses aimed at 
studying neuronal differentiation and has great potential in nerve injury repair as 
well as neuron prosthesis. 
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RIASSUNTO 
 
I nanotubi di carbonio (CNTs) sono i candidati ideali per lo sviluppo di supporti 
volti a promuovere la rigenerazione neurale grazie alla loro abilità di condurre gli 
stimoli elettrici e alla loro nanotopografia in grado di mimare l'ambiente neurale. 
Questo lavoro riguarda lo sviluppo di supporti nanocompositi costituiti da CNTs 
dispersi in una matrice di acido polilattico (PLLA) e quindi in grado di combinare 
le caratteristiche nanotopografiche e di conduttività dei CNTs con la 
biocompatibilità del PLLA. Tali supporti, sono risultati essere in grado di 
supportare la crescita e il differenziamento delle cellule neuronali SH-SY5Y in 
modo migliore rispetto al solo PLLA. Al fine di mimare gli stimoli guida 
dell'ambiente neurale, sono stati sintetizzati anche dei peptidi biomimetici 
ricavati da specifici motivi regolativi delle proteine L1CAM e LINGO1, le quali 
sono coinvolte nel controllo dell'accrescimento neuritico. Entrambi i peptidi non 
hanno dimostrato effetti negativi sulla vitalità e la proliferazione cellulare, 
promuovendo invece il differenziamento neuronale in modo sequenza specifico 
e con i maggiori effetti quando utilizzati a concentrazione 1 M. Inoltre, quando 
usati in combinazione, supporti e peptidi sono in grado di agire in modo sinergico 
e di aumentare ulteriormente il differenziamento cellulare.  
Successivamente, al fine mimare al meglio l'ambiente neurale, la matrice CNT-
PLLA è stata elettrospinnata in fibre di dimensione submicrometrica con lo scopo 
di rappresentare i processi neuronali e la componente collagenosa della matrice 
extracellulare. Tali supporti si sono rivelati essere biocompatibili e in grado di 
promuovere la formazione di nuovi neuriti che si allungano seguendo 
l'orientamento delle fibre del supporto. Dal momento che le cellule sono 
influenzate dalla topografia del supporto, l'allineamento delle fibre suggerisce la 
possibilità di poter ottenere una crescita neuritica polarizzata. Inoltre, le 
proprietà neuritogeniche del supporto aumentano quando il peptide derivato da 
LINGO1 viene aggiunto al terreno di coltura; questi risultati rappresentano un 
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buon punto di partenza per sviluppare supporti più avanzati a seguito della 
funzionalizzazione con tale peptide. In aggiunta, cellule circolanti multipotenti 
umane (hCMCs) sono state coltivate sui supporti e trattate con i peptidi al fine di 
determinare se tale fonte di cellule staminali autologa ed accessibile sia capace 
di differenziazione neuronale grazie soltanto alle caratteristiche dei supporti e 
dei peptidi. I supporti CNT-PLLA e la rispettiva versione elettrospinnata sono 
risultati essere adatti all'adesione e alla crescita delle hCMCs, mostrando buoni 
livelli di biocompatibilità; inoltre, le hCMCs coltivate sui supporti hanno mostrato 
caratteristiche tipiche delle cellule neuronali come lunghe protrusioni neuritiche 
terminanti con strutture a forma di ventaglio simili ai coni di crescita. I supporti 
inoltre promuovono l'espressione di marcatori tipici del lignaggio neuronale. 
Anche i peptidi si sono rivelati essere in grado di influenzare la morfologia 
cellulare e di upregolare marcatori neuronali. Questi risultati suggeriscono che le 
hCMCs sono capaci di acquisire un commitment neuronale solo grazie alle 
caratteristiche dei supporti e dei peptidi e senza l'ausilio dei fattori di crescita 
che sono tradizionalmente usati per promuovere il differenziamento neuronale 
di cellule staminali. Sono necessari ulteriori studi riguardanti la composizione e 
geometria dei supporti, funzionalizzazione con i peptidi e condizioni di coltura 
per acquisire una completa differenziazione neuronale e controllare il tipo 
neuronale ottenuto; ma tale sistema sembra essere un buon punto di partenza 
per progettare supporti trapiantabili per promuovere la rigenerazione neurale. 
Sarebbe interessante poter valutare la trasmissione sinaptica e le proprietà 
fisiologiche delle cellule cresciute sui supporti così come utilizzare tali supporti 
per stimolare elettricamente le cellule e valutare un eventuale miglioramento nel 
differenziamento.  
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ABBREVIATIONS 
 
a.m.u.: Actual peptide mass 
APP: amyloid precursor protein  
BDNF: Brain-derived neurotrophic factor  
bFGF: basic fibroblast growth factor  
Calcein-AM: Calcein acetoxymethyl ester  
CAMs: Cell adhesion molecules 
CD: Circular dichroism  
CMCs: Circulating multipotent cells  
CNS: Central nervous system 
CNT-PLLA scaffold: CNT dispersed in the PLLA matrix 
CNTs: Carbon nanotubes 
CRASH:Corpus callosum hypoplasia, Retardation, Adducted thumbs, Spasticity and Hydrocephalus 
CREB: cAMP response element-binding protein  
CT: Threshold cycle  
DAT: Dopamine transporter  
dBcAMP: dibutyryl cyclic AMP  
DMEM/F-12: Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12  
DMSO: Dimethyl sulfoxide  
DRG: Dorsal root ganglion  
DSC: Differential scanning calorimetry  
ECM: Etracellular matrix 
eCNT-PLLA: electrospun CNT-PLLA scaffold 
EGFR: Epidermal growth factor receptor  
EN: Ethylenediamine  
ePLLA: electrospun PLLA  
ESCs: Embryonic stem cells  
FBS: Foetal bovine serum 
FDA: Food and Drug Administration 
FGFR:Fibroblast growth factor receptor  
FITC: Fluorescein isothiocyanate  
Fmoc: Flurenylmethyloxycabonyl 
Fn: Fibronectin  
GDNF:Glial-derived neurotrophic factor  
GFAP: Glial fibrillar acidic protein 
GFP: Green fluorescent protein 
HBSS: Hank's Balanced Salt Solution 
Ig: Immunoglobulin  
iPSCs: induced pluripotent stem cells  
LDH: Lactate dehydrogenase  
LINGO1: LRR and Ig-like domain containing Nogo receptor interacting protein 
LRR: Leucine rich repeat  
MAP2: Microtubule associated protein 2  
MEAs: Multi-electrode arrays  
MTs: Microtubules  
MWCNTs: Multi-walled carbon nanotubes 
NCAM: Neural cell adhesion molecule 
NeuN: Neuronal nuclear antigen  
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NFM: neurofilaments  
NGF: Nerve growth factor  
NSCs: Neural stem cells  
NT-3: Neurotrophin 3  
PABS: Poly-m-aminobenzene sulfonic acid 
PBS: Phosphate buffered saline 
PCL: Poly(ε-caprolactone) 
PCR: Polymerase Chain Reaction 
PD: Parkinson’s disease  
PGA: Poly(glycolic acid)  
PGFs: Phosphate glass microfibers  
PhOMe: Methoxyphenyl group 
PI: polyimide  
PLDLA: poly(l/d-lactic acid)  
PLGA: Poly(lactic acid-co-glycolic acid)  
PLLA: Poly(L-lactic acid)  
PPy: Polypyrrole 
qPCR: Quantitative Real time RT-PCR  
RA: all-trans-retinoic acid  
RARE: Retinoic acid response element  
RARs: Retinoic acid receptors  
REST: Repressor Element-1 Silencing Transcription factor  
RMSD: Root mean square deviation 
RH: Relative humidity  
ROS: Oxygen reactive species 
RP-HPLC: Reversed-phase high-performance liquid chromatography  
RTKs: Receptor tyrosine kinases 
RXRs: Retinoid X receptors  
SAMs: Self-assembly monolayers  
SCI: Spinal cord injury  
SEM: Scanning electron microscopy 
SYP: Synaptophysin 
SWCNTs: Single-walled carbon nanotubes 
TBI: Traumatic brain injury  
TGA: Thermogravimetric analyses  
TPA: Phorbol ester 12-O-tetradecanoylphorbol-13-acetate  
TRKB: Tyrosine receptor kinase B  
TUBβ3: Tubulin β III 
VAMP7: Vesicle associated membrane protein 7  
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1. INTRODUCTION 
 
1.1 REGENERATIVE MEDICINE 
 
Regenerative medicine and tissue engineering evolved as interdisciplinary 
technologies combining principles from the life, material and engineering 
sciences with the goal of restoring the function of damaged tissues by delivering 
a combination of cells, biological factors and biomaterial scaffolds on which cells 
can adhere, proliferate, differentiate and organize similarly to native tissue.  
Multiple approaches have been developed, depending on variety of injured 
tissue type and injury entity: 
1) Scaffolds functionalized with factors are implanted to recruit progenitor 
cells at the defective site to stimulate their differentiation; 
2) Stem cells are loaded onto the scaffold in vitro, and after their 
differentiation the cell-scaffold composite is implanted into the defective 
site. 
Figure 1. An example of a tissue engineering strategy. Cells are isolated from the 
patient (A) and may be cultivated in vitro on two-dimensional surfaces (B) for efficient 
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expansion. Next, the cells are seeded onto scaffolds (C) together with growth factors, 
small molecules, and micro- and/or nanoparticles. The cell constructs are further 
cultivated in bioreactors to allow cell differentiation (D) and then transplanted (E) into the 
damaged site to restore its function. (Adapted from Dvir et al., 2011). 
 
1.1.1 MULTIPLE CUES TO IMPROVE REGENERATION 
 
The cells reorganize via multiple interactions with the extracellular environment 
that provides topographical and mechanical stimuli, concentration gradients of 
growth factors or extracellular matrix (ECM) molecules and electrical signals. 
Therefore, scaffolds for regenerative medicine should recapitulate/mimic as 
more such features of the native tissue environment as possible in order to 
properly provide cells with information important for differentiation and tissue 
development (Dvir et al., 2011).  
 
Figure 2. Multiple cues to improve regeneration. Regenerative medicine strategies try 
to incorporate different biosignals to recreate a controlled environment to direct stem cell 
tissue-specific differentiation.  
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1.1.1.1 Biochemical cues 
 
Biochemical cues are provided by reciprocal interactions between the cell, 
soluble bioactive agents, and the ECM. Such biochemical cues are able to 
interacts with cell receptors activating signalling cascade and determining cell 
differentiation. Most of them fall within three categories: 
 
 insoluble ECM macromolcules (e.g. collagens, elastin and laminin), 
glycoproteins (e.g. fibronectin and vitronectin), as well as polysaccharides 
such as heparan sulfate and hyaluronic acid. In vivo, these ECM proteins 
form a meshwork of fibres or fibrils with ECM glycoproteins incorporated 
into them. The resulting matrix functions as both a structural and 
signaling scaffold to cells; 
 
 diffusible/soluble molecules such as growth factors, chemokines and 
cytokines. Growth factors are naturally occurring protein hormones 
which may act through autocrine or paracrine mechanisms and have 
potent effects on cell growth, proliferation, and differentiation. Growth 
factors are often stored and sequestered in the ECM and interact with 
cells through receptor tyrosine kinases (RTKs). 
 
 Cell-cell receptors such as cadherins, cell adhesion molecules (CAMs), and 
ephrins. Cell-cell receptors are crucial to intercellular communication and 
regulate cell behaviours like proliferation and differentiation. 
 
1.1.1.1.1 Synthetic peptides for mimicking protein regulatory motifs 
Many works showed that some of the aforementioned molecules - if 
administrated both in vitro and in vivo - are able to elicit specific cell responses 
(Alberts et al., 2003); moreover, different strategies have been developed to link 
such proteins to biomaterial scaffolds in order to help delivery at the injured 
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sites (Matsumoto et al., 2007). However, coating surfaces with recombinant 
proteins or native matrix macromolecules extracted from animal tissues 
encounters the problem of eliciting immunoresponses, in particular when using 
proteins from different species. Furthermore, their isolation and purification 
from native tissues or their production as recombinant proteins at larger scale 
for tissue engineering purposes is expensive and subjected to batch to batch 
variability (Von der Mark et al., 2010). Moreover, protein conformation may be 
changed by immobilization onto the scaffold surface and the polypeptide chain 
orientation is difficult to control or even to predict. For these reasons, the 
production of specific motifs known to mediate regulatory signals as synthetic 
peptides presents significant advantages compared to using entire 
recombinant/native tissue proteins: (i) low immunogenic activity, (ii) increased 
stability, (iii) low production costs and (iv) simplified preparation and 
immobilization onto substrates. Moreover, peptides can be: (v) presented to 
cells at surface densities significantly higher than those possibly achieved with 
entire proteins or domains and (vi) tailored in composition for each tissue -
specific application (Chen et al., 2008). The biomimetic peptides most used for 
scaffold functionalization are the ones representing the ECM protein epitopes for 
integrin binding and therefore promoting cell adhesion (Shekaran et al., 2010); 
however, the laminin IKVAV epitope for integrin binding has been shown to 
promote and enhance neurite elongation and neuronal differentiation of neural 
progenitor cells (Silva et al., 2004). Furthermore, some peptides mimetic of 
growth factors have been developed to promote cell survival and differentiation; 
for example, after the identification of specific loops important for nerve growth 
factor (NGF) function, peptides corresponding to these active regions were 
produced, showing good NGF agonist activity and cell differentiation trough the 
activation of tyrosine kinase receptor A (Colangelo et al., 2008). Once a protein 
structure is solved, several mimetic peptides can be designed; for example, a 
number of peptides reproducing homophilic binding sites of the neural cell 
adhesion molecule (NCAM) have been synthesized and they are able to interfere 
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with neuronal cell adhesion molecules and to promote differentiation and cell 
survival (Berezin et al., 2004).  
 
Figure 3. Biochemical signals from the extracellular environment. Insoluble ECM 
macromolecules; soluble diffusible factors and cell–cell receptors interact with cells 
controlling their proliferation and differentiation. (Adapted from Shekaran et al., 2010). 
 
1.1.1.2 Physical cues 
 
Cells are capable of sensing and responding to biophysical cues, over a wide 
range of length scales. Many of these cues are provided by the ECM, which acts 
as a cellular scaffold and is the primary extracellular component in tissues. In 
vivo, the ECM, through its structure and molecular composition, presents a 
variety of geometrically defined, three-dimensional (3D) physical cues in the 
submicron to micron scale, referred to as topographies. Cell response to 
topographies is mediated by a phenomenon called contact guidance, which is 
known to affect cell adhesion, morphology, migration, and differentiation 
(Nikkhah et al., 2012). Another physical cue displayed by the ECM is mechanical 
stiffness through which, similar to topography, a diverse set of cellular functions 
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can be modulated. Matrix sensing requires the ability of cells to pull against the 
matrix and cellular mechano-transducers to generate signals based on the force 
that the cell must generate to deform the matrix. Mechano-sensitive pathways 
subsequently convert these biophysical cues into biochemical signals that 
commit the cells to a specific lineage (Engler et al., 2006). Neurons are able to 
transduce topographical stimuli through interaction of the growth cone with the 
immediate environment and mechanical cues that can direct neurite extension. 
Guided neurite and axonal growth ensures appropriate and regulated 
connectivity within the overall neural circuitry, giving rise to specialized nuclei 
with specific functions within the brain (Pettikiriarachchi et al., 2010). 
 
1.1.1.2.1 Electrospun fibres for mimicking ECM topography 
The architecture of ECM is of special importance because it supports 3D cellular 
networks to form tissues and control many cellular behaviours. Electrospun 
polymer fibrous substrates with controlled fibre architectures and diameter 
provide topographical cues to cells by presenting geometries mimetic of the 
scale and 3D arrangement of the collagen and laminin fibrils of the ECM. Such 
polymer fibres present an high surface-to-volume ratio and porosity and are 
hence well suited for promoting cell adhesion, growth and differentiation and 
enable growth factor/drug loading; such properties are inherent to bioactive 
matrix microniches (Landers et al., 2014). In the case of neuronal precursor cells, 
it has been shown that fibre diameter is able to control their differentiation; 
specifically, small nanofibers, which mimic a glial-like morphology, result in a 
differentiation biased toward an oligodendrocyte fate. On the other hand, 
scaffolds composed of largerfibres, which restricted cell spreading along a single 
fibre,improve differentiation towards the neuronal lineage (Christopherson et 
al., 2009). Electrospun scaffolds also have the ability to control cell morphology 
and, in the case of neuronal cells, the direction of neurite elongation (Cirillo et 
al., 2014). 
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1.1.1.2.2 Electrospinning technique 
Electrospun fibres are generally obtained through the electrospinning technique.  
This unique approach uses electrostatic forces to generate thin fibres from 
polymer solutions and the fibres thus produced have a thinner diameter (from 
nanometer to micrometer) and a larger surface area than those obtained with 
traditional spinning processes.  
Figure 4. Schematic diagram of set up of electrospinning apparatus.(Adapted from 
Bhardwaj et al., 2010). 
 
Furthermore, a direct current voltage in the range of several tens of kVs is 
required to generate theelectrospinning. This process is founded on the principle 
that strong mutual electrical repulsive forces overcome weaker forces of surface 
tension in the charged polymer liquid (Chew et al., 2006). Electrospinning is 
conducted at room temperature with atmosphere conditions and consists of 
three major components:a high voltage power supply, a spinneret (e.g., a pipette 
tip) and a grounded collecting plate (usually a metal screen, plate, rotating 
mandrel) and utilizes a high voltage source to inject charge of a certain polarity 
into a polymer solution, which is then accelerated towards a collector of 
opposite polarity. Most of the polymers are dissolved in some solvents before 
electrospinning, and when it completely dissolves, forms polymer solution. The 
polymer fluid is then introduced into the capillary tube for electrospinning. In the 
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electrospinning process, a polymer solution held by its surface tension at the end 
of a capillary tube is subjected to an electricfield and an electric charge is 
induced on the liquid surface due to this electric field. When the electric field 
applied reaches a critical value, the repulsive electrical forces overcome the 
surface tension forces. Subsequently, a charged jet of the solution is ejected 
from the tip of the spinneret and an unstable and a rapid whipping of the jet 
occurs toward the collector which leads to evaporation of the solvent, leaving a 
polymer behind. (Bhardwaj et al., 2010).  
 
1.1.1.3 Electrical cues 
 
Endogenous electrical signals are present in many developing systems and crucial 
cellular behaviours - such as cell division, cell migration, and cell differentiation -
are all under the influence of such electrical cues (Yao et al., 2011). This is 
particularly true for neuronal cells in which electric signals activate membrane 
receptors and downstream intracellular signalling elements leading to 
asymmetrical activation/redistribution of the cytoskeleton and the consequent 
cell polarization. Indeed, some studies suggested the involvement of electrical 
activity in pathfinding of growing axons and the formation of initial connections 
in the developing nervous system (Yao et al., 2009). Moreover, it was discovered 
that an endogenous electric field arises at the onset of neural tissue repair 
(Huang et al., 2012). 
 
1.1.1.3.1 Conductive materials for mimicking electrically conductive tissues 
Neural circuits generate spontaneous electrical activity due to the 
electrophysiological properties of their constituent neurons and connections. 
Neuronal electrophysiological and synaptic properties can be affected by 
neuron-surface interactions, in particular for cells growing onto a substrate 
characterized by an inherent electrical conductivity. For these reasons, 
electroactive materials are the best choice to mimic the features of electrically 
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conductive tissues and to interface with neural cells providing electrical shortcuts 
between developing cells and a platform for supporting neuronal network 
activity and regeneration (Schmidt et al., 1997; Lovat et al., 2005). Moreover, 
electrically conductive scaffolds may improve cell survival and functional 
integration after transplantation in vivo by providing structural support for 
transplanted cells and facilitating synaptogenesis with host cells. Furthermore, 
electrically conductive materials can also allow application of electrical stimuli 
that can mimic the electrophysiological environment experienced by cells in a 
variety of biological processes, including muscle contraction, wound healing, and 
synaptic transmission (Landers et al., 2014) 
 
1.1.2 CELLS HAVE MICRO- AND NANOMETER SENSITIVITY 
 
Cells have micro and nanoscale sensitivity because the extracellular environment 
presents a variety of spatially defined cues in the the sub-micron to micron scale: 
 At the nanometer level, extracellular environment affects sub-cellular 
behaviors such as the organization of cell adhesion molecule receptors; 
 At the micron level, extracellular environment affects cellular and 
supracellular characteristics such as cell morphology and migration 
(Nikkhah et al., 2012). 
Therefore, in order to mimic such submicron ECM organization, nanomaterials 
and nanotechnology tools can be used to develop special biomaterials able to 
recapitulate the architecture and spatial organization of structural proteins 
within ECM and the nanoscale features that model native ECM nanotopography 
(Shekaran et al., 2010). This approach - able to precisely regulate cell 
differentiation, morphology and polarization - is fundamental in order to proceed 
with clinical applications.  
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Figure 5. The relative scale of biological molecules and structures. 
 
Combinations of stimulatory cues may be used to incorporate nanoscale 
topographical, chemical and electrical cues in the same scaffold to provide an 
environment for tissue regeneration that is superior to inert scaffolds. 
 
1.2 NANONEUROSCIENCE 
 
Nanomaterials can take advantage of their unique molecular features to induce, 
with high specificity, a number of desired physiological responses in target cells 
and tissues, while minimizing undesirable effects (Silva et al., 2006). 
Nanoneuroscience is an emerging field combining nanotechnology, chemistry, 
engineering and neurobiology. The application of nanotechnology to neural 
tissues is of particular interest because neural cells are electroactive and the 
electronic properties of nanostructures can be tailored to match the charge 
transport requirements of electrical cellular interfacing. The peculiar mechanical 
and chemical properties of nanomaterials can be exploited for integration with 
neural tissue in long term implants; moreover, their nanoscale features have the 
potential to interact with the biological system at the molecular scale, while 
offering elevated levels of control (Kotov et al., 2009). Indeed, recent studies 
regarding the interaction of nanomaterials with neural systems have provided a 
foundation for generating a new class of multifunctional devices and hybrid 
systems that could help in the repair of damaged nervous tissue, and that have 
paved the road to nanoneuroscience as a new discipline (Sucapane et al., 2009).  
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Figure 6. Applications of nanotechnologies in neuroscience. Nanomaterials and 
nanodevices that interact with neurons and glia at the molecular level can be used to 
influence and respond to cellular events. In all cases, these engineered technologies allow 
controlled interactions at cellular and subcellular scales. (A) Chemically functionalized 
fluorescent quantum dot nanocrystals used to visualize ligand–target interactions. (B) 
Surfaces modified with neurotransmitter ligands to induce controlled signalling. (C) 
Engineered materials with nanoscale physical features that produce ultrastructural 
morphological changes. (D) Surfaces and materials functionalized with different neuronal-
specific effector molecules, such as cadherin and laminin, to induce controlled cellular 
adhesion and growth. (Adapted from Silva et al., 2006). 
 
1.2.1 NANOPATTERNING OF MOLECULES FOR GUIDING CELL ORGANIZATION 
 
Molecular deposition and lithographic techniques allow the patterning of 
neuronal-specific molecules with nanometre resolutions. The deposition of 
proteins/peptides and other molecules that promote and support neuronal 
adhesion, growth and differentiation on regenerating scaffolds enables the 
selective adhesion and growth of neural cells and a controlled neurite extension 
along the geometric pattern (Staii et al., 2011). 
 
1.2.2 NANOTOPOGRAPHY FOR CONTROLLING CELL BEHAVIOURS 
 
The nanoscale physical features of the scaffolds can affect neuronal behaviour. 
Natural tissues have indeed a hierarchical structure ranging from the macroscale 
(>1 mm), to microscale (1 m – 1 mm), and nanoscale (< 1 m). As a result, 
individual cells (typically in the size range 10-50 m) respond in different ways to 
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structures at different length scales. It was shown that integrin receptors possess 
characteristic dimensions on the order of 10 nm (Comisar et al., 2006). The 
basement membrane of organs consists of nanoscale fibres (line topography) 
and pores (holes) that range in diameter from a few nanometers to several 
hundred nanometers (Abrams et al., 2000). The tubular fibers of collagen also 
have nanoscale dimensions (Curtis et al., 2001) and Laminin shows nanoscale 
texture as well (Rodríguez Hernández., et al., 2007). Given that cells' ECM is 
patterned down to the nanoscale, cell-biomaterial interactions in scaffolds can 
be optimized by incorporating features of nanoscale dimensions. Indeed, 
surfaces topographically structured at the submicron scale can affect a wide 
variety of growth parameters, such as cell adhesion, morphology, viability, 
genetic regulation, apoptosis, motility and differentiation (Gaharwar et al., 
2013). Recent evidence from nanoscale topography analysis suggests that 
nanoscale features eliciting cell response are in the same size range (50-70 nm) 
that is associated with integrin cluster formation (Arnold et al., 2004). Further 
studies showed that scaffold nanotopography can control cell fate by altering cell 
and nucleus shapes, hence activating intracellular signal transduction and silent 
gene expression (Kim et al., 2012; Yang et al., 2013). This is particularly true for 
neurons that, thanks to their growth cones, sense and actively respond to the 
surface nanotopography with a surprising sensitivity to variations of few 
nanometers (Brunetti et al., 2010). In such a context, great potential is 
represented by Carbon Nanotubes (CNTs): thanks to their nanometer dimensions 
and high aspect ratio they could be used to develop nanotextured substrates 
influencing cell behaviours. Nanostructured surfaces have therefore the 
potential to define new types of interactions between scaffolds and cells: the 
scaffold surface area increases and can better resemble the native neural tissue. 
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1.2.3 NANOELECTRODS FOR SELECTIVE STIMULATION OF TARGETED NEURONAL 
POPULATIONS 
 
Another emerging area of neuroscience nanotechnology regards the materials 
and devices designed to stimulate neurons. Neural prostheses, for example, are 
assistive devices to restore lost neuronal functions. These devices electrically 
stimulate nerves replacing injured neurons and fine control at molecular level is 
crucial to develop devices able to properly interact with the nervous system. 
Given that size should be small enough to enable selective stimulation of a 
targeted population of neurons (Schmidt et al., 2003; Silva et al., 2006), 
nanomaterial based neural electrodes are likely to improve signal transfer 
specificity and to reduce as well glial scarring at the injured site. Again, the 
conductive features and nanometric size of CNTs render them ultimate materials 
for developing/coating such electrodes. 
 
1.2.4 NANOCARRIERS FOR DRUG DELIVERY 
 
Another area in which nanotechnology may significantly impact in clinical 
neuroscience is the development of nanocarriers able to selectively deliver 
drugs, peptides, and oligonucleotide to specific regions or tumors to improve 
their pharmacological activity and simultaneously diminishing their undesirable 
systemic side effects. Thanks to their nanometric dimensions, such nanocarriers 
can be exploited to cross the blood brain barrier to target therapeutics to the 
Central Nervous System (CNS) (Silva et al., 2007). CNTs possess a number 
intriguing features that make them attractive drug delivery carriers:(i) they 
exhibit high accumulation in tumor tissues; (ii) their needle-like shape facilitates 
transmembrane penetration and intracellular accumulation of drugs via the 
"nanoneedle" mechanism that is independent of additional CNTfunctionalization 
and cell types; (iii) aside from direct translocation through cellular membranes, 
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CNTs are also able to enter cells via energy-dependent endocytic pathways; (iv) 
as a platformfor drug attachment, CNTs, owing to their high aspect ratios and 
surface areas, display extraordinary ability for drug loading onto the surface or 
within the interior core of CNTs via both covalent and non-covalent interactions 
(Wong et al., 2013). 
 
1.3 THE NERVOUS SYSTEM: INJURY AND REGENERATION 
 
The CNS consists of the brain and the spinal cord. The peripheral nervous system 
(PNS) is located outside the CNS and includes the cranial, spinal and peripheral 
nerves that conduct impulses from and to the CNS. Injury in peripheral nerves 
could lead to loss of neuronal communication along sensory and motor nerves 
between the CNS and the peripheral organ scausing reduction in motor and 
sensory functions. CNS injury, like traumatic brain injury (TBI) or stroke, can 
result in several symptoms including cognitive, motor and psychotic dysfunction. 
(Pettikiriarachchi et al., 2010; Arslantunali et al., 2014).  
 
1.3.1 NEURONS AND NEURITE OUTGROWTH 
 
Neurons are polarized cells involved in the synaptic transmission of much 
information necessary for regulating all biological functions. The formation of 
neural circuits in the brain requires that a correct connectivity is established 
between neurons during development. Every neural circuit is represented by the 
structure of axons and dendrites, with individual axons stimulating multiple 
targets, and single dendrites assimilating inputs from various sources. During 
nervous system development, neurons extend axons to find their final 
destination toward a complex and changing environment and establish a 
functional synaptic network. Each axon is tipped with the growth cone; such a 
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specialized structure shows highly dynamic behaviour and responsiveness to 
multiple sources of spatial information and is hence able to guide the axon itself 
toward right targets with an impressive level of accuracy. The growth cone 
travels on a road made up of adhesive molecules presented on a neighbouring 
cell surface, such as transmembrane CAMs or assembled into a dense ECM 
(including laminin and fibronectin). These molecules provide defined "roadway" 
surfaces to which growth cone receptors can adhere, but they also activate 
intracellular signalling pathways utilized by the growth cone guidance machinery. 
Additionally, anti-adhesive surface-bound molecules (such as e.g. Slits and 
Ephrins) can prohibit growth cone advance and thus provide "guardrails" that 
determine roadway boundaries. Finally, diffusible chemotropic cues represent 
the "road signs" that present further steering instructions to the travelling 
growth cone. It is clear now that the response of attraction versus repulsion is 
not due to the intrinsic property of the cue, but rather to the specific receptors 
engaged and the internal signalling milieu of the growth cone (Lowery et al., 
2009).  
Figure 7. Directions for the trip. The growth cone encounters many different types of 
cues in its environmental terrain. It travels on a 'road' that is made up of adhesive 
molecules that are either presented directly on a neighbouring cell or assembled into a 
dense and complex extracellular matrix. Additionally, anti-adhesive surface-bound 
molecules can prohibit growth cone advance and thus provide the 'guard rails' that 
determine the road boundaries. (Adapted from Lowery et al., 2009). 
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Structural organization is central to growth cone function. The leading edge 
consists of dynamic, finger-like filopodia that explore the road ahead. Filopodia 
are separated by membrane sheets called lamellipodia-like veils. The cytoskeletal 
elements in the growth cone underlie its shape, and three growth cone regions 
can be distinguished based on cytoskeletal distribution. The peripheral (P) 
domain contains long F-actin bundles, which form the filopodia, as well as mesh-
like branched F-actin networks, which give structure to lamellipodia-like veils. 
Additionally, individual dynamic "pioneer" microtubules (MTs) explore this 
region, usually along F-actin bundles. The central (C) domain encloses stable, 
bundled MTs that enter the growth cone from the axon shaft, in addition to 
numerous organelles, vesicles and central actin bundles. Finally, the transition (T) 
zone sits at the interface between the P and C domains, where actomyosin 
contractile structures lie perpendicular to F-actin bundles and form a 
hemicircumferential ring. The dynamics of these cytoskeletal components 
determine growth cone shape and movement on its journey during development 
(Lowery et al., 2009).  
The growth cone engages its cytoskeleton to drive forward and turn, 
continuously influenced by environmental factors. The binding of the growth 
cone receptor to an adhesive substrate induces the generation of a complex that 
acts like a molecular "clutch", mechanically coupling the receptors and F-actin 
flow, thus anchoring F-actin to prevent retrograde flow and driving actin-based 
forward growth cone protrusion on the adhesive substrate. Traction also 
requires myosin II. Filopodia are guidance sensors located at the "front line" of 
the growth cone and they might have a major role in establishing growth cone-
substrate adhesive contacts during environmental exploration. Several studies 
show that filopodia function as substrate attachment points and produce tension 
needed for growth cone progression. In order for spatial discontinuities in the 
environment to drive growth cone steering and, in particular, to accurately 
interpret numerous cues simultaneously, the growth cone requires a 
"navigation" system that translates multiple environmental directions through 
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Rho-family GTPases to locally modulate the dynamics of the cytoskeletal 
machinery including F-actin retrograde flow and F-actin guidance of MTs, in 
order to introduce spatial bias for steering the growth cone in the right direction 
(Lowery et al., 2009). 
Figura 8. Growth cone structure. P domain contains (i) long, bundled actin filaments 
that form filopodia and (ii) mesh-like branched F-actin networks forming lamellipodia-like 
veils. C domain is formed by stable, bundled MTs, organelles, vesicles and stable actin 
bundles. T zone sits at the P-C domains interface, where contractile actomyosin structures 
lie perpendicular to F-actin bundles and form a hemicircumferential ring. (Adapted from 
Lowery et al., 2009). 
 
1.3.2 PNS INJURY 
 
Peripheral nerve injury leads to loss of neuronal communication along sensory 
and motor nerves between the CNS and the peripheral organs and depending on 
site of injury this can severely impair the quality of life of a patient (Arslantunali 
et al., 2014). Injuries are most commonly attributable to direct mechanical 
trauma, and less frequently, surgical resection secondary to tumour excision. 
However, the PNS has an intrinsic ability for repair and regeneration and such 
capacity relates to age of patient, mechanism of injury and in particular to the 
proximity of the injury to the nerve cell body; indeed often the nerve gaps are 
too big to be naturally regenerated (Faroni et al., 2014).  
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Reinnervation of denervated targets can be achieved by regeneration of injured 
axons or by collateral branching of undamaged axons in the proximity. However, 
often such mechanisms do not provide a complete functional recovery, 
especially after severe injuries. Neuronal response and axon regeneration imply 
complex interactions among different cell types as well as changes in the 
expression of many molecules. Failure in axon regeneration after peripheral 
nerve injury may depend on decreased intrinsic properties of neurons, absence 
of neurotrophic factors, or presence of inhibitory factors (Hsu et al., 2013). The 
withdrawal of target-derived neurotrophic support leads to profound changes in 
gene and protein expressions whose balance determines if the neuron survives 
and attempts regeneration or undergoes apoptosis (Reid et al., 2009). If 
regeneration is promoted, the distal stump of the injured nerve undergoes a 
series of molecular and cellular changes known as Wallerian degeneration. 
Within a few hours, both the axon and the myelin in the distal stump degenerate 
and macrophages migrate to the site of injury and contribute to debris clearance. 
In the first 24 hours, Schwann cells proliferate and switch from a myelinating to a 
regenerative phenotype and exhibit up-regulation of several molecules that 
assist the parallel degenerative and regenerative processes. In particular, the 
denervated Schwann cells downregulate structural proteins such as myelin basic 
protein and myelin-associated glycoprotein, whilst they upregulate L1-CAM, 
Neural-CAM, glial fibrillary acidic protein and many growth factors such as nerve 
growth factor (NGF), brain-derived neurotrophic factor (BDNF), glial-derived 
neurotrophic factor (GDNF), basic fibroblast growth factor (bFGF) and 
neurotrophin 3 (NT-3). Once debris is removed by the combined action of 
macrophages and Schwann cells, these latters align to form columns. This in turn 
provides a permissive environment rich in trophic factors, enabling guided axonal 
regeneration (Scheib et al., 2003; Faroni et al., 2014). Distal to the injured site, 
there are many obstacles for the regenerating axon to overcome prior to 
successfully reinnervate the target organ. Misdirection towards the wrong target 
reduces functional outcome even when the number of regenerated axons is 
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good; however, this is checked by "pruning" of growth cones that do not reach 
the correct target or lose support of their endoneurial tubes. Lack of neuronal 
contact in the distal stump leads to chronically denervated Schwann cells which 
downregulate growth factors and enter a dormant state, unable to support 
axonal progression. Similarly, the denervated target organ is exhausted of 
trophic factors, muscle fibres atrophy and satellite cells undergo apoptosis. 
These responses bear a significant impact on functional recovery following 
proximal nerve injuries (Fig. 9A) (Faroni et al., 2014). 
 
1.3.3 CNS INJURY 
 
CNS axons do not regenerate appreciably in their native environment. Several 
glycoproteins in the native extracellular environment (myelin) of the CNS are 
inhibitory for regeneration. The physiological response to injury in the CNS is also 
different compared to that of the PNS. After injury in the CNS, macrophages 
infiltrate the site of injury much more slowly compared to infiltration in the PNS, 
delaying the removal of inhibitory myelin. This largely depends on the blood-
spine barrier, which limits macrophage entry into the nerve tissue to just the site 
of injury, where barrier integrity is weakened. In the case of spinal cord injury , 
cell adhesion molecules in the distal end of the injured nerve are not upregulated 
appreciably as they are in the PNS, limiting macrophage recruitment. Finally, 
astrocytes proliferate in a manner similar to that of Schwann cells in the PNS, but 
become "reactive astrocytes" producing glial scars that inhibit regeneration (Fig. 
9B) (Schmidt et al., 2003). 
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Figure 9. Responses to axotomy in the PNS and spinal cord. (A) In the PNS, support 
cells aid neuronal regeneration. Proliferating Schwann cells, macrophages, and monocytes 
work together to remove myelin debris, release neurotrophins, and lead axons toward 
their synaptic targets, resulting in restored neuronal function. (B) In the CNS, however, 
the few neurons that survive axotomy attempt regeneration and subsequently meet an 
impenetrable glial scar composed of myelin and cellular debris, as well as astrocytes, 
oligodendrocytes, and microglia. Fibroblasts, monocytes, and macrophages may also be 
present in the glial scar. Consequently, regenerating neurons in the spinal cord are 
blocked from reaching their synaptic target. (Adapted from Schmidt et al., 2003). 
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1.3.4 CURRENT CLINICAL APPROACHES FOR TREATING NERVE INJURIES 
 
For peripheral nerve injury, treatments typically consist of either direct end-to-
end surgical reconnection of the damaged nerve ends or the use of an 
autologous nerve graft. Suturing the ends of the two nerve ends together can 
repair small defects or gaps in the nerve. For longer nerve gaps, this approach is 
not desired because any tension introduced into the nerve cable would inhibit 
nerve regeneration. Thus, for a larger nerve defect, an autologous nerve graft 
that is harvested from another site in the body is used to span the injury site (Fig. 
10A). Disadvantages of this technique include loss of function at the donor site 
and the need for multiple surgeries.  
The development of therapies for spinal cord injury (SCI), traumatic brain injury 
(TBI), and other pathologies affecting CNS is more challenging due to the 
inhibitory environment that the injured axon has to face. Some attempts has 
been done attacking the inhibitory factors that suppress axonal regeneration. 
Active research is indeed focusing in the development of therapeutics able to 
counteract the myelin-associated inhibitors (e.g. LINGO1, NgR, Nogo, MAG). 
Various studies, both in vivo and in vitro, showed the ability of such therapeutics 
to suppress the inhibitory activity of glial scarring at the site of the injury and 
hence they are promising candidates for overcome the CNS injured axon inability 
to regenerate (GrandPre et al., 2002; Cho et al., 2012; Mi et al., 2013).  
Furthermore, CNS axons have the ability to regenerate into PNS grafts and 
various groups have observed long distance regeneration with this approach 
(David et al., 1981; Tom et al., 2009). Within peripheral nerve grafts, parallel 
columns of Schwann cells surrounded by basal lamina render excellent guidance 
to regenerating axons. However, harvesting autografts is limited by tissue 
availability and donor site morbidity, and the alternative acellularized allografts 
fail to support axonal regeneration (Hurtado et al., 2011). 
Treatment with growth factors showed the ability to promote neuronal survival 
and axon regeneration in vitro, but such a strategy is clinically problematic, when 
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considering the side-effect profile, the timing and method of growth factor 
release and the unpredictable interactions between growth factors and 
heterogeneous neuronal population (Faroni et al., 2014). However, some 
attempts have been done by delivering growth factors at the injured site using 
various types of nanocarriers. Other regenerative approaches regard the 
transplantation of stem cells at the injured site to favour tissue reconstruction 
and axon regeneration by replacing damaged neural tissues. Some works showed 
the ability of transplanted cells to undergo neuronal differentiation and then 
substitute lost neuronal and glial populations (McDonald et al., 1999; Chow et 
al., 2000; Cizkova et al., 2007); other studies demonstrated instead that stem 
cells are able to support axonal regeneration thanks to their own trophic activity 
and to sustain axon remyelination by differentiating into glial cells (Cízková et al., 
2006; Wright et al., 2011). 
An alternative strategy could be the use of biomaterial scaffolds incorporating 
multiple cues to more closely mimic native environment, thus promoting neural 
induction, axonal regeneration and neuroprotection.  
 
1.3.4.1 Nerve guidance scaffolds 
 
Spinal cord injury or pheripheral nerve repair requires "bridging" the lesion with 
a matrix that provides a permissive environment, fills the tissue gap and, 
concomitantly, provides structural support for axonal regrowth and functional 
reconnection. When the nerve graft is not possible, a valid alternative could be 
the development of nerve conduits able to guide the regenerating axons across 
the gap to connect with the distal end (Fig. 10B). Only then will signal 
transduction occur (Xu et al., 2014). An ideal nerve conduit needs to be 
biocompatible, flexible, neuroinductive, able to conduct electrical stimuli, tear 
resistant and sterilizable (Verreck et al., 2005). A number of materials have been 
proposed for use in neural tissue engineering. These include biodegradable, 
either natural or synthetic, as well as non-biodegradable polymers. Among the 
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biomolecules, the most studied and used are polyesters (poly(3-
hydroxybutyrate) and poly (3-hydroxybutyric acid-co-3-hydroxyvaleric acid)), 
proteins (silk, collagen, gelatin, fibrinogen, elastin, and keratin), and 
polysaccharides (hyaluronic acid, chitin and alginate). Although aforementioned 
molecules are potentially able to sustain regeneration, their use is greatly limited 
by batch-to-batch variation and possibility to induce immunogenic reactions 
(Schmidt et al., 2003; Pego et al., 2012; Arslantunali et al., 2014). Synthetic 
polymers are attractive alternatives, as many of them are biocompatible and can 
elude the host immune response; moreover, their mechanical properties can be 
controlled and they can be processed in various forms to enhance tissue 
ingrowth. Many polymers, such as poly(L-lactic acid) (PLLA), poly(glycolic acid) 
(PGA), poly(lactic acid-co-glycolic acid) (PLGA), poly(ε -caprolactone) (PCL), 
polyurethanes (PUs), tri-methylene carbonate-co-ε-caprolactone, poly(D,L-
lactide-co-ε-caprolactone), methacrylate-based hydrogels, polystyrene, silicone, 
and poly(tetrafluoroethylene), have already been used to create neural scaffolds 
(Schmidt et al., 2003; Pego et al., 2012; Arslantunali et al., 2014). PLLA for 
example is already FDA approved for use in tissue engineering application 
(Schmidt et al., 2003) and used as nerve conduit to promote regeneration of 
sciatic nerves and spinal cord in animal models (Evans et al., 1999; Oudega et al., 
2001). In recent years, importance of the alignment in nerve guide conduits was 
understood, and conduits endowed with topographical cues as grooves and 
electrospun fibres were developed to direct the outgrowth of elongating 
neurites (Li et al., 2008; Liu., et al 2010). Hurtado et al, for example, developed a 
conduit formed by aligned electrospun PLLA fibres that successfully promote the 
regeneration of spinal nerves after a complete spinal cord transection (Hurtado 
et al., 2011). Moreover, as an electrically conducting tissue, the scaffold should 
likewise be able to conduct an electrical signal. In a recent study, PLLA was 
blended with polypyrrole (PPy) to produce a conducting nerve conduit; in vitro 
studies showed PC12 cell differentiation was improved when cells were seeded 
onto such conduits while in vivo studies demonstrated that these conductive 
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conduits behave like autologous nerve graft in repairing rat sciatic nerve defect 
suggesting that conducting materials have a great potential for nerve tissue 
regeneration (Xu et al., 2014). 
 
Figure 10. Bioartificial nerve graft for nerve repair. Autograft (A). Artificial nerve graft 
that consists in nerve guide which could be enriched with several factors to enhance 
axonal regrowth (B). (Adapted from Faroni et al., 2014). 
 
1.3.4.2 Biomaterials for brain repair 
 
The objective of brain tissue engineering is to repair, replace, and regenerate 
tissue at the damaged site in order to re-establish functionality at both the 
cellular and organ levels. For these reasons, bioactive scaffolds are produced 
with the aim to provide a microenvironment that could facilitate survival, 
proliferation, differentiation, and connectivity of transplanted and/or 
endogenous cells. Many strategies have been developed so far to promote 
regeneration after brain injury, of which some require the implantation of 
scaffolds at the injured site in order to retrieve endogenous neural progenitors 
favouring their differentiation. Other strategies are based on implanting scaffolds 
to encourage the elongation of existing axons and - when massive cell lost occurs 
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- to use scaffolds for delivering stem cells at the injured site hence promoting a 
more rapid connectivity. A range of scaffolds including hydrogels, self-assembling 
peptides, and electrospun nanofibre scaffolds have been investigated as 
candidates for neural tissue engineering within the brain. It is essential for these 
scaffold that the surface properties are optimized to support endogenous or 
implanted cells and to possibly provide guided axonal growth (Pettikiriarachchi et 
al., 2010). Electrospun scaffolds are really interesting for such applications as 
their fibrillar architecture is mimetic for ECM topography and their large surface 
area to volume ratio and porosity can facilitate cell and axon penetration, 
neurite contact guidance as well as diffusion and waste of nutrients (all factors 
known to enhance scaffold–tissue integration). It is noteworthy that aligned 
fibrous scaffolds prepared by electrospinning are able to orient neurite growth 
whereas random organization promote neurite penetration (Nisbet et al., 2009). 
As for peripheral and spinal nerve conduits, various natural and synthetic 
polymers have been explored to develop electrospun scaffolds; a recent study 
demonstrates for example that PCL electrospun scaffold loaded with BDNF 
mimetic implanted toward the subventricular zone of rats mobilizes endogenous 
neuroblasts that are able to infiltrate the scaffold and differentiate (Fon et al., 
2014). Great attention has been given to electroactive materials which can 
facilitate communication between neurons in the brain: for example, PCL and 
PLLA nanofibrous scaffolds were coated with PPy to form conductive sheaths and 
dorsal root ganglion cells were shown to extend longer neurite when subjected 
to electrical stimulation (Xie et al., 2009). Similar results were obtained by 
culturing PC12 cells onto a scaffold formed by electrospun PLLA fibres coated 
with PPy (Lee et al., 2009). 
 
1.3.4.3 Nanostructured scaffolds for neural tissue engineering 
 
A main problem with PPy and other conductive polymers is that their 
conductivity may change under harsh environment (Chao et al., 2009). For this 
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reason, CNTs are being increasingly used for developing neural regenerating 
scaffolds. It is expected that scaffold incorporated with CNTs can enable 
electrical stimulation and CNTs can be used into in vivo devices that could 
interact directly with neurons. All such unique CNT characteristics hold great 
technological promise for neuron related medical applications.  
 
1.4 CARBON NANOTUBES (CNTS) 
 
Since their discovery in 1991 by Iijima, CNTs have attracted wide interest in most 
fields of science and engineering due to their unique physical and chemical 
characteristics. These properties allow them to be used in a wide range of 
applications. The major areas of CNTs research are the polymer composites and 
biomedical devices including scaffold for regenerative medicine, biosensors, cell 
tracking and drug delivery carriers. 
CNTs are cylindrical nanostructures whose simplest geometry is that of a single-
walled nanotube (SWCNT). Here, a single graphene sheet (one-atom thick layer 
of carbon atoms arranged in a regular hexagonal pattern) is rolled up and closed 
at each end by a hemispherical fullerene cap; SWCNT diameters typically range 
between 0.8 and 2 nm with a tube length that can be many millions of times 
longer. Multi-walled nanotubes (MWCNT), on the other hand, are composed of  
numerous (by two up to hundreds) layer of graphene wrapped concentrically. 
Depending on the number of layers, MWCNTs have a larger diameter that can 
reach 100 nm (Sucapane et al., 2009). 
Figure 11. Schematic diagrams of 
single-walled carbon nanotube 
(SWCNT) and multi-walled carbon 
nanotube (MWCNT). SWCNTs consist 
of a single graphene sheet rolled up 
into a cylinder (left figure); MWCNTs 
consist of multiple concentric 
cylindrical shells of graphene sheets 
(right figure). (Adapted from 
Choudhary et al., 2011). 
 
 29 
 
1.4.1 CNT-BASED SCAFFOLDS FOR NEUROLOGICAL APPLICATIONS 
 
CNTs are attractive candidates for developing scaffolds to be used in neurological 
applications thanks to their morphology and nanoscale dimensions, their tunable 
electrical conductivity, their mechanical properties, and chemically modifiable 
surface. 
 
1.4.1.1 CNTs nanotopography favours cell adhesion and neuronal 
differentiation 
 
CNT structural features and dimensions resemble the smallest neuronal 
processes and many components of neuronal extracellular environment as 
proteins of the ECM (e.g. collagen), ion channels, signaling proteins and 
cytoskeletal elements (Fabbro et al., 2013).  
Indeed, it has been found that such CNT nanoroughness - that matches the size 
of the neural environment roughness - contributes to anchor the neuronal cells. 
It was shown that, when seeded onto a CNT film, neuronal processes entangle 
around CNT nanostructures improving the binding of their membranes to the 
CNT surface (Sorkin et al., 2009). Furthermore, neuronal growth cones were 
shown to establish tight contacts with the CNT surface, and these strong 
interactions allowed the neurons to spread and interact with one another (Zhang 
et al., 2005).  
CNTs - thanks to their chemical properties and enhanced surface area provided 
by a needle-like shape - have a good capacity to adsorb adhesion proteins from 
the serum, such as e.g fibronectin and laminin (Khang et al., 2007; Chao et al., 
2010; Stout et al., 2012). Therefore, when cells grow onto CNT-based scaffold, 
they show enhanced capacity to form focal adhesions by clustering integrin 
molecules and hence, increased cell adhesion (Kim et al., 2012). In addition to 
favouring adhesion, CNT-based capacity to adsorb proteins results in trapping 
growth factors produced by the cells during their differentiation and this in turn 
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creates a storage site that can progressively release such growth factors during 
cell maturation, in a "signal-buffered" environment suitable for long term 
neuronal differentiation (Chen et al., 2013). At a glance, CNT ability to mimic 
neural environment topography and to retain proteins and growth factors would 
help and enhance cell adhesion, growth and neuronal differentiation.  
 
1.4.1.2 CNT functionalization improves the scaffold properties 
 
CNTs can be functionalized by covalent or non-covalent chemistry to improve 
their solubility in organic solvents, to modify their surface charge or to attach 
biologically active molecules able to promote neuronal cell adhesion and 
differentiation. 
CNTS are highly hydrophobic and may contain residual impurities such as 
amorphous carbon and metallic nanoparticles; however, the surface 
 
Figure 12. MWCNT film trap neural growth factors which are secreted from the cells. In 
contrast, these proteins in the control group cannot be kept but are washed out every 
time the medium is replaced. (Adapted from Chen et al., 2013) 
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functionalization of CNTs by chemically attaching organic functional groups helps 
the CNT materials in becoming biocompatible and improves their solubilization in 
organic solvents for obtaining more homogeneous material. Two main paths are 
usually followed for the functionalization of CNTs: (i) attachment of organic 
moieties to the carboxylic groups that are formed by oxidation of CNTs with 
strong acids or (ii) direct bonding to the surface double bonds. Such strategies 
have been explored to engineer CNT surfaces by attaching bioactive molecules 
mediating specific biological responses (Saifuddin et al., 2013).  
Such bioactive molecules can be linked to CNT surfaces also through non 
covalent functionalization, which is based on weak forces (van der Waals, 
hydrophobic or π-π interactions) unable to retain for long periods the interacting 
molecules. However, non covalent functionalization does not affect CNT charge 
and interacting molecules can adsorb to the external sides of nanotube, but also 
the adsorption to the internal side is possible (endohedral functionalization) 
(Hirsch et al., 2002). 
The first use of CNT substrate for neuro-interfacing applications was reported by 
Mattson and colleagues, who cultured embryonic rat hippocampal neurons onto 
a coverslip coated with MWCNTs. Such a study demonstrated that pristine 
MWCNT substrates promoted cell adhesion while blocking neurite outgrowth. 
However, the non-covalent functionalization with 4-hydroxynonenal(4-HNE),a 
molecule promoting neurite elongation, showed a great increase in the number 
of neurite per cell and total neurite length (Mattson et al., 2000). Therefore the 
CNT functionalization resulted to be a valid method to improve scaffold 
performance. Later, Hu et co-workers studied the effect of surface charge 
modification: the MWCNT substrate charge was modified by functionalization 
with carboxyl groups, poly-m-aminobenzene sulfonic (PABS) acid or 
ethylenediamine (EN) to create negatively, zwitterionic or positively charged 
CNTs, respectively. Improved neurite elongation and branching were found when 
cells were seeded onto positively charged CNT scaffolds, according to the known 
preference of neuronal cells for positive substrates such as poly-lysine (Hu et al., 
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2004). Therefore, manipulation of CNT surface charge can be successfully used to 
tune neurite outgrowth. Covalent functionalization with bioactive molecules was 
also explored; Matsumoto at al., covalently functionalized MWCNTs with NGF 
and BDNF and used them to culture embryonic chick dorsal root ganglion (DRG) 
neurons. DRG neurite outgrowth on modified MWCNTs was comparable to that 
seen with soluble NGF and BDNF in culturing media; therefore, such study 
indicated that CNT covalent functionalization with biomolecules allows the 
attached factors to maintain their bioactivity (Matsumoto et al., 2007).  
 
1.4.1.3 CNTs incorporation in polymer scaffolds supports cell 
growth and maturation 
 
CNTs are among the toughest and strongest nanomaterials; moreover, they are 
flexible and can be easily combined with both natural and synthetic polymers in 
developing scaffolds able to support neuronal cell adhesion and growth.  
The incorporation of CNTs into polymeric scaffolds can be used to ameliorate the 
polymer scaffold characteristics:  
 
 CNT can reinforce polymeric scaffold mechanical properties; indeed it 
has been shown that, increasing the percentage of incorporated 
CNTs, the scaffold toughness and tensile strength also increase 
(Kharaziha et al., 2014). Therefore, the CNT percentage within the 
scaffold can be modulated in order to mimic the ECM mechanical 
properties of the tissue of interest; 
 
 CNTs can reduce the polymer electrical resistance. Indeed, it has been 
shown that, due to the CNT needle-like shape and high aspect ratio, 
their percolation threshold (the critical concentration where a 
transition from non-conducting to conducting state occurs) in 
polymer matrix composites is achieved at low concentrations ranging 
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from 0.0025 to 4 wt% . This allows for the modulation of the polymer 
electrical properties, without changing other important aspects as 
processability (Lizundia et al., 2012); 
 
 CNTs feature a nanoscale meshwork within the polymer scaffolds and 
this could be of help to cell adhesion, as cells prefer rough surfaces 
(Bareket-Keren et al., 2013). 
 
Different type of composites have been developed by combining CNT with 
polymers; for example, Jin and collaborators demonstrated that MWCNT-PLCL 
scaffolds showed improved adhesion, proliferation and neurite outgrowth of PC-
12 cells (Jin et al., 2011). The in vivo studies using CNT-polymer devices are still 
very few, but a very recent report from Yu et al., showed that MWCNT-enhanced 
electrospun collagen/PCL conduit promote regeneration of sciatic nerve defects 
in rats and prevent muscle atrophy without invoking body rejection or serious 
chronic inflammation (Yu et al., 2014). Furthermore, Ahn and colleagues 
reported that CNTs chemically tethered onto the surface of aligned phosphate 
glass microfibers (PGFs) were successfully placed into three-dimensional 
poly(l/d-lactic acid) (PLDLA) tubes. After implantation of a CNT–PGF nerve 
conduit into the 10 mm gap of a transected rat sciatic nerve, the number of 
regenerating axons crossing the scaffold, the cross-sectional area of the re-
innervated muscles and the electrophysiological findings were all significantly 
improved by interfacing with CNTs, thus demonstrating an effective role for CNTs 
in nerve regeneration (Ahn et al., 2015). 
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1.4.1.4 CNT conductivity boosts neuronal electrical signaling and 
differentiation 
 
CNTs are electrically conductive and their conductivity is stable in biological 
environment (Chen et al., 2009). Therefore, their inherent electrical conductivity 
can mimic the features of the electrically conductive nervous tissue promoting 
neuronal maturation and excitability.  
Lovat and co-workers found hippocampal neurons grown onto a MWCNT grid to 
show an enhanced network activity compared to those seeded onto control glass 
coverslips. The authors suggested that the increase in the efficacy of neural 
signal transmission may be due to the specific properties of CNT conductivity, 
able to provide a pathway allowing direct electrotonic current transfer, which in 
turn results in charge redistribution along the surface of the membrane. (Lovat et 
al., 2005). Similar results were obtained by using a substrate of SWCNTs for 
culturing hippocampal neurons: in this case very tight contacts between CNTs 
and neuronal membrane were shown by scanning electron microscopy (Fig. 13), 
hence supporting the hypothesis that improved neuronal electrical signals 
depends on CNT properties rather than on difference in neuronal survival or 
morphology (Mazzatenta et al., 2007). A further study clearly showed by 
transmission electron microscopy that CNTs can pinch neuronal membranes; 
when such neurons are forced to fire, CNT substrates strongly impact on single-
cell regenerative electrical properties possibly due to electrical shortcut between 
adjacent dendritic compartments mediated by the conductive substrate (Cellot 
et al., 2009). Therefore, this study suggests a direct electrical coupling between 
CNTs and neuronal membranes. It was shown that other substrates for neuronal 
growth, mimicking either conductivity or nanoroughness of CNTs, are not able to 
enhance dendritic regenerative ability, thus suggesting that both properties are 
necessary for CNT substrates to influence neuronal activity (Cellot et al., 2009). 
Moreover, it was demonstrated with hippocampal neurons that SWCNT 
substrates can promote de novo formation of synapses characterized by an 
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improved efficacy (Cellot et al., 2011). CNTs scaffolds were also tested with 
three-dimensional cell cultures: in a study performed with spinal cord explants, 
beside the increase of fibres outgrowing the spinal tissue and the high growth 
cone activity, an increased synaptic efficacy was revealed even in neurons 
located at as far as 5 cell layers from the cell substrate interactions (Fabbro et al., 
2012). Beside electrical signaling, the conductivity of CNT scaffolds can be 
modulated in order to control cell differentiation. Malarkey and co-workers 
studied SWCNT scaffolds with different conductivities and the same 
nonoroughness and found that rat hippocampal neuron neurite outgrowth 
changes depending on narrow ranges of conductivity (Malarkey et al.,2009). 
Therefore, the conductivity of the scaffold - modulating both neuronal 
differentiation neuronal electrical signaling - can be finely tuned to enhance 
scaffold performance. 
 
Figure 13. SEM images of cultured hippocampal neurons on SWNTs. (C, D) 
Subsequent micrographs at higher magnifications of neurons grown on SWNT. (E, F) 
Details of the square in (D) showing the interaction between neuronal membrane and 
SWNT. Scale bar (in E): C, 25 µm; D, 10 µm; E, 2 µm; F, 450 nm. (Adapted from Mazztenta 
et al., 2007). 
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1.4.1.5 CNT substrates can be used to electrically stimulate neurons 
 
CNT-based scaffolds can also be used to stimulate cultured neurons; indeed, it 
was shown that the application of a current through the CNT substrates resulted 
in an inward transmembrane current that was indistinguishable from those 
induced by direct patch-clamp electrode-mediated depolarizing voltage steps 
(Liopo et al., 2006; Gheith et al., 2006). The effects of electrical stimulation 
through CNT scaffolds were analyzed: Huang and colleagues used a SWCNT rope 
as a substrate to cultivate and electrically stimulate NSCs and demonstrated that 
electrical stimulation boosted NSCs towards differentiated neurons in the early 
culture stage, when compared to conventional tissue culture plates via the 
analysis of neuronal gene and protein expressions (Huang et al., 2012). Landers 
et al. showed that, even when incorporated into polymer electrospun scaffolds, 
SWCNTs can be exploited to electrically stimulate cells, and the authors noted 
and enhanced NSC differentiation ability after electrical stimulation (Landers et 
al., 2014). Cho et al. demonstrated that electrical stimulation of PC-12 cell 
through a CNT/collagen composite can strongly improve neurite extension (Cho 
et al., 2010). Therefore, electrical stimulation through CNT-based matrixes can 
directly carry electrical current to control neuronal differentiation and neurite 
extension. This could be of benefit for developing novel neural electrodes and for 
enhancing and controlling cell behaviours in an electrically driven way. 
CNTs have been successfully explored as coating material for metal electrodes. 
CNT coating enhanced both recording and electrical stimulation of neurons in 
culture, rat motor cortex and monkey visual cortex respect to bare metal 
electrodes. This improvement was due to reduced electrode impedance and 
increased charge transfer. Therefore, CNT-coated electrodes are expected to 
favour the development of long-lasting brain–machine interface devices (Keefer 
et al., 2008).  
However, the major step toward implantable neuro-prosthetics applications is 
the development of flexible multi-electrode arrays (MEAs). Recently, a flexible 
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MEAs based entirely on CNT technology - where both the conducting traces and 
the stimulating electrodes consist of conducting CNT films embedded in a 
polymeric support - have been developed and showed a great suitability for high-
efficacy neuronal stimulation applications (David-Pur et al., 2014).  
 
1.4.1.6 CNTs can act as guidance cues for neurite outgrowth 
 
Morphological guidance of regenerating axons is necessary to facilitate the 
formation of an effective neural network. CNT patterns have been shown to act 
as guidance cues for axonal growth, hence demonstrating a good potential in 
clinical applications . 
Zhang et al., used a combination of microlithography and chemical vapor 
deposition to engineer patterned vertical MWCNT substrates. They found that 
neurons preferentially adhered to MWCNT patterns and growth cones were 
attached to the CNT surface, allowing the neurons to spread along patterns and 
interact with one another (Zhang et a l., 2005). Park and colleagues developed 
patterns of CNTs onto the biocompatible polymer polyimide (PI) by means of 
self-assembly monolayers (SAMs) and microcontact printing techniques. Such 
patterns were used for culturing hNSCs, showing that cells preferentially adhere 
in correspondence of the CNT patterned surfaces, and that CNT geometries can 
be modulated to tune both cell nuclei localization and neurite extension along 
the CNT patterns. Interestingly, the authors showed that such control on cell 
polarization can be obtained at single cell level (Park et al., 2011). Also when CNT 
are combined to other materials, it is possible to obtain some kind of control on 
neurite directionality; for instance, Jin et al. used CNT for coating aligned 
electrospun PLCL nanofibers and cultured DRG neurons and PC-12 cells; such 
coating could improve the outgrowth of neurites along the scaffold fibres (Jin et 
al., 2011). 
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Figure 14. hNSC growth and differentiation on biocompatible and flexible PI 
substrate with CNT pattern. Phase contrast image of selective hNSC adhesion on CNT 
patterns on PI after cell seeding. Scale bar represents 200 μm (c). Immunofluorescence 
image of the differentiated hNSCs on CNT patterns on PI (TUJ1 for neural cells and GFAP 
for astroglial cells). The inset shows the magnified image of the region marked by the 
white solid square. Scale bar represents 200 μm, and that of the inset represents 50 μm. It 
should be noted that the orientation-controlled neural networks were constructed along 
the CNT patterns on the PI membrane (d). (Adapted from Park et al., 2011). 
 
Thanks to their conductivity stable in biological environment and able to boost 
neuronal electrical signaling, their nanotopographical features resembling 
neuronal processes and the possibility to be conjugated with bioactive molecules 
and polymers, CNTs show the great potential to be used as implants where long-
term extracellular molecular cues for neurite outgrowth are necessary. 
Furthermore, their nanometer dimensions, low impedance and high conductivity 
allow their use to develop stimulating electrodes to replace lost neuronal 
functions. Therefore, CNTs seem to be at the meeting point between neural 
regeneration strategies and neural prosthetics and further open up new avenues 
for biomedical applications. 
 
1.4.2 CNT CYTOTOXICITY 
 
The CNT cytotoxicity is still a debated issue and mainly concerns with types, 
functionalization and doses of CNTs being employed and the cell populations 
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tested. Pristine CNTs are water insoluble and packed in bundles or aggregates in 
aqueous solutions. They usually have impurities, typically amorphous carbon, 
graphite nanoparticles, and transition-metal catalyst particles that have been 
shown to create cytotoxicity both in vitro and in vivo: 
 
 CNTs can penetrate the cells membranes, then being eliminated through 
renal excretion; for these reasons and thanks to their high loading 
capacity, CNTs have been widely investigated as drug delivery agents 
(Lacerda et al., 2008). However, depending on their length, CNTs can 
accumulate in the cytoplasm leading to cell death (Porter et al., 2007); 
 
 insoluble pristine CNTs form bundles or aggregates in aqueous solutions. 
It was reported that, after intraperitoneal administration in mice, SWCNT 
bundles above 10 µm in length may induce granuloma formation 
(Kolosnjaj-Tabi et al., 2010); 
 
 transition-metal catalyst may induce the formation of oxygen reactive 
species (ROS) with oxidative stress (Pulskamp et al., 2007). 
 
The problem with impurity and insolubility has now been alleviated using a 
number of purification techniques and a wide variety of noncovalent and 
covalent methods for CNT functionalization. This strongly improved CNT level of 
biocompatibility (Cui et al., 2010). Therefore, it is very important to optimize 
type, doses, length and functionalization of CNTs being employed for each 
specific application.  
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1.5 PROTEINS INVOLVED IN NEURITE OUTGROWTH 
 
1.5.1 L1CAM 
 
Neural L1 cell adhesion molecule (L1CAM) plays a pivotal role in correct CNS 
development in humans, as it is involved in several activities important to CNS 
maturation, including neurite outgrowth, adhesion, fasciculation, migration, 
myelination and axon guidance. L1CAM promotes these cellular activities by 
interacting with a diverse group of CAMs, ECM molecules and signaling receptors 
through homo- and heterophilic interactions involving its extracellular region. L1 
is composed of six immunoglobulin (Ig)-like domains and five fibronectin (Fn) 
type-III repeats in the extracellular region, a single pass transmembrane region 
and a short cytoplasmic tail. Tertiary structure of L1 is as yet unsolved; however, 
it is likely that the first four Ig domains Ig1-Ig4 exist in a dynamic equilibrium 
between extended and folded (horseshoe) conformations similar to that of the 
related proteins hemolin and axonin-1. L1 is exposed at the surface of both 
differentiating and differentiated neurons as well as on glial cells and it binds to a 
diverse set of molecules, sending intracellular signals through its cytoplasmic 
region (Kenwrick et al, 2000; Haspel et al., 2003). Two soluble forms of the L1 
extracellular domain can be generated by proteolytic cleavage within the third Fn 
repeat or between the fifth one and the transmembrane region. Such soluble 
forms are able to promote neurite elongation by “conditioning” the extracellular 
matrix (Kalus et al., 2003; Maretzky et al., 2005). In particular, neurite outgrowth 
is triggered by homophilic binding in trans occurring between two L1 molecules 
that activate fibroblast growth factor receptors (FGFR) (Kenwrick et al., 2000). 
Even though it has been demonstrated that the Ig1-Ig4 region is the minimal 
contiguous segment necessary to mediate homophilic binding (Gouveia et al., 
2008), a larger segment encompassing Ig1-Ig6 is needed to reproduce the 
biological potency of native L1 (Haspel et al., 2000; De Angelis et al., 2002). 
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Interestingly, a particular 14 amino acid long region was mapped within the 2nd Ig 
domain (Ig2) as a key fragment necessary for the initial interaction between two 
L1 molecules. Zhao et al., in 1998 produced this region as a synthetic peptide 
(called L1-A: 178-HIKQDERVTMGQNG-191) and demonstrated its capacity to 
mediate adhesion. In particular, they mixed GST-Ig2-conjugated covaspheres 
with L1-A peptide before seeding onto a substratum coated with GST-Ig2 and L1-
A was found to inhibit binding of covaspheres to substrate-coated GST-Ig2, 
possibly because of peptide competition for the homophilic binding between the 
two Ig2 domains. As a negative control, they used a number of designed 
mutants. One such mutant, R184A, is of special interest as it resulted in fully 
impaired activity (inability to bind to Ig2 domain), hence underling the 
importance of the conserved Arg residue in L1 homophilic binding (Zhao et al, 
1998). It is noteworthy that mutations regarding Arg 184 are causative for CRASH 
(Corpus callosum hypoplasia, Retardation, Adducted thumbs, Spasticity and 
Hydrocephalus) syndrome and the most severe phenotype known is given R184Q 
substitution (De Angelis et al., 2002).  
Figure 15. Schematic representation of L1 ectodomain and signaling activated by 
the homophilic binding.L1 ectodomain is composed by six Ig-like domains (Ig1–6) and 
five fibronectin type III domains (FnIII1–5). Proteolytic cleavages within repeat Fn3 and 
between Fn5 and the transmembrane region generate L1 ectodomain soluble forms (A). 
L1 homophylic binding is mediated by the Ig2 domain and activates FGFR stimulating 
neurite outgrowth (B) (adapted from Kamiguchiet et al., 1997 (A) and from Kenwrick et 
al., 2000 (B)). 
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1.5.2 LINGO1 
 
Leucine rich repeat (LRR) and Ig-like domain containing Nogo receptor 
interacting protein (LINGO1) is a transmembrane protein that is selectively 
expressed in the CNS and plays an important role in neurite outgrowth control. 
LINGO1 is formed by 12 LRR motifs flanked by N- and C-terminal capping 
domains, one Ig-like domain, a transmembrane region and a short cytoplasmic 
tail. This latter contains an epidermal growth factor receptor (EGFR)-like 
phosphorylation site (Tyr 591). LINGO1 is highly conserved evolutionarily, with 
human and mouse orthologues sharing 99.5% identity (Mi et al., 2004; Llorens et 
al., 2008). LINGO1 forms at the neuron surface a complex with Nogo66-Receptor 
NgR1 (ligand binding subunit) and the neurotrophin receptor p75 (transducing 
subunit). NgR1/LINGO1/p75 complex interacts with Mag/NogoA/OMgp complex 
at the oligodendrocyte surface and inhibits neurite elongation by activating RhoA 
pathway (Mi et al., 2004). NgR1/LINGO1/p75 complex also interacts with 
neuronal NogoA, thus blocking neurite elongation and generating repulsion 
between neurites (Petrinovic et al., 2010). Moreover, LINGO1 can homophilically 
interact in trans, suggesting that LINGO1 molecules from adjacent neuronal and 
oligodendrocytic membranes might interact and inhibit oligodendrocyte final 
differentiation (Jepson et al., 2012). Furthermore, LINGO1 interacts with both 
EGFR and Tyrosine receptor kinase B (TRKB) inhibiting Akt signaling pathway and 
hence survival and neurite outgrowth (Inoue et al., 2007; Fu et al., 2010). Recent 
evidence shows that, despite LINGO1 extracellular domain is composed by 
twelve LRR and one Ig domain, this latter alone mediates homophilic binding and 
heterotypic interactions (Stein et al.; 2012). The LRR domain, instead, is mainly 
involved in homotetramerization and in hindering potential interactions with 
partners by the highly glycosylated concave faces of its extended, arc-shaped 
architecture (Mosyak et al., 2006). LINGO1 expression is high during embryo 
development to maintain the growing axons en route and away from uncorrect 
targets; its expression decreases during post-natal life but it is upregulated again 
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after injury to avoid regeneration (Mi et al., 2004). Furthermore, LINGO1 is 
involved in several CNS diseases: LINGO1 is an interacting partner of the amyloid 
precursor protein (APP) in vivo and cellular co-expression of LINGO1 with APP 
was found to augment the release of the αβ peptide, the presumed causative 
agent of Alzheimer’s disease (Bai et al., 2008). Moreover, LINGO1 interacts with 
the APP only thanks to its Ig domain (Stein et al., 2011). LINGO1 seems to be 
involved also in Parkinson’s disease (PD) and multiple sclerosis as its expression 
has been found elevated in the substantia nigra of PD patients (Inoue et al., 
2007) and in oligodendrocyte progenitor cells from demyelinated white matter 
of multiple sclerosis post-mortem samples (Mi et al., 2013). In vitro and in vivo 
studies showed that LINGO1 inhibition (dominant-negative LINGO1 
transmembrane form, soluble LINGO1-Fc; anti-LINGO1 antibodies) promotes 
neurite elongation, neuron and oligodendrocyte survival, axon regeneration, 
oligodendrocyte differentiation, remyelination and functional recovery (Mi et al., 
2004; Ji et al., 2006; Inoue et al., 2007; Mi et al., 2013; Fernandez-Enright et al., 
2014).  
Figure 16. Signaling pathways for LINGO1 function. Neuronal NgR1/LINGO1/p75 
complex interacts with Mag/NogoA/OMgp complex at the oligodendrocyte surface 
and inhibits neurite elongation by activating RhoA pathway. LINGO1 blocks TRKB and 
EGFR activation by inhibiting Akt signalling and neurite outgrowth. The homophilic 
binding between two LINGO1 molecules inhibits oligodendrocyte final differentiation, but 
effects at the neuronal level are still poorly understood.  
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Therefore, LINGO1 seems to be one of the molecules responsible for CNS 
neurons inability to regenerate and thus it represents an ideal candidate for 
therapeutic targets in neural dysfunctions because of its restricted tissue 
distribution. 
 
Figure 17. LINGO1 ectodomain structure. Ribbon diagram showing the overall 
architecture of the LINGO1 monomer, coloured according to secondary structure: beige, 
coil; blue, ß strand; red, α-helix. Disulfide bonds are shown in green, and N-linked 
carbohydrates are yellow (A). View of the top and front surfaces of the LINGO1 tetramer, 
rendered in red, green, magenta, and yellow. The two views are related by 90° rotation 
with respect to the horizontal axis. Carbohydrate are shown as yellow sticks. The LRR 
modules interlock the ring head-to-tail, back-to-back and the Ig domains extend 
vertically. The bottom view illustrates the putative orientation of the tetramer relative to 
the cell surface (B). (adapted from Mosyak et al., 2006). 
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1.6 STEM CELLS AND NEURONAL DIFFERENTIATION 
 
1.6.1 STEM CELLS IN REGENERATIVE MEDICINE 
 
Regenerative therapeutics using stem cells is a promising approach for the 
treatment of a variety of neurological diseases and both PNS and CNS injuries. 
Stem cells have multipotency to differentiate into specific lineages under 
different inducing conditions, making them a powerful tool for the regeneration 
of the biological function of injured tissues (Kim et al., 2012). It is well known 
that the interaction between stem cells and the extracellular microenvironment 
is critical in controlling stem cell differentiation. Control of cell fate 
determination can be achieved by creating a niche that mimics the ECM surface 
topography, mechanical properties, and chemical microenvironment (Chao et al., 
2009). Concerning neuronal regeneration, it is important to ensure both 
complete neural induction of cells and morphological guidance of neurite 
outgrowth, thus facilitating the formation of an effective neural network (Park et 
al., 2011; Kim et al., 2012).  
 
1.6.2 STEM CELLS FOR NEURAL REPAIR 
 
Different types of stem cells have the potential to be exploited in neurological 
application. Embryonic stem cells (ESCs) are pluripotent stem cells that can be 
isolated from the blastocyst, an early-stage embryo. ESCs cells represented a 
promising source for cell transplantation because of their ability to differentiate 
into all somatic cell lineages, but their clinical use has remained somewhat 
hampered by the ethical implications of using human embryos. However, use of 
human induced pluripotent stem cells (iPSc) rather than ESCs begun to help 
overcome these issues. However, the tumorigenic potential of iPSCs remains a 
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great concern. Neural stem cells (NSCs) are thought to be an optimal cell source 
for the treatment of neurological disorders because of their potential to 
differentiate into cells of glial and neuronal lineage.However, there are ethical 
problems surrounding the use of foetal tissues associated with abortion and they 
are difficult to isolate from autologous brain biopsies. Mesenchymal stem cells 
(MSCs) are adult stem cells that are found mainly in the bone marrow; despite 
their mesenchymal origin, they showed the ability to differentiate into neurons 
under proper conditions and they offer the possibility of the autologous 
transplant (Wang et al., 2013). However, they are generally isolated from the 
iliac crest of the patient and therefore through a quite invasive method. A very 
valid alternative is represented by circulating multipotent cells (CMCs) thanks to 
their accessibility and the potential to differentiate into neurons (Di Liddo et al., 
2012a-b). 
 
1.6.2.1 Human circulating multipotent cells (hCMCs) 
 
hCMCs are adult stem cells isolated by ficoll density gradient separation from 
human donor peripheral blood. hCMCs are mononucleated and have fibroblastic 
morphology during long term culture with a doubling population time of 48 
hours over 31 passages; they show by flow cytometry immunophenotypical 
similarities to mesenchymal stem cells (CD105, CD166, CD73, CD29) and meso-
angioblasts (CD34) (Di Liddo et al., 2012a). hCMCs have an intrinsic trophic 
activity able to establish a regenerative microenvironment at sites of tissue 
damage. Indeed, they secrete several cytokines and growth factors able to 
control their own proliferation and differentiation. hCMCs have been shown to 
be extremely sensible to changes in culture conditions that lead to sudden gene 
expression shifts and cell differentiation. They can be differentiated into 
progenitors for several mesenchymal tissues as adipocytes, osteoblasts, 
chondroblasts or muscle cells and; when treated with specific cocktails of growth 
factors, they are capable of neuronal differentiation as confirmed by immunoblot 
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analysis of the expression of TUBβ3 (Tubulin β III), MAP2 (Microtubule associated 
protein 2), NeuN (Neuronal nuclear antigen), SYP (Synaptophysin), Musashi, 
NCAM, dopamine transporter (DAT) and neurofilaments (NFM) (Di Liddo et al. 
2012b). 
Figure 18. hCMCs differentiation into different cell types. hCMCs are isolated from 
peripheral blood and have the ability to differentiate into adipocytes, chondroblasts, 
osteoblasts, muscle cells and neurons under proper culture conditions.  
 
The high degree of plasticity and the expression of a peculiar pattern of surface 
antigens not attributable to other defined adult stem cell populations, are 
consistent with the hypothesis that hCMCs belong to a new adult stem cell niche. 
These cells represent an attractive option for a wide range of regenerative 
medicine applications as hCMCs are (i) free from tumorigenisis risk sometimes 
associated to induced pluripotent stem cells (iPSCs), (ii) accessible, (iii) not 
subjected to ethical restrictions and (iv) a valid method to avoid rejection 
problems thanks to the autologous transplant. 
 
1.6.3 NEURONAL MARKERS 
 
Some of the markers that are generally analyzed to evaluate the differentiation 
of stem cells toward the neuronal lineage are the follows: 
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 Nestin is a class IV intermediate filament protein and a neural progenitor 
marker, therefore it is highly expressed in undifferentiated cells during 
nervous system development. After cell differentiation into neurons or 
glial cells, Nestin expression decreases and it is substituted by cell type-
specific intermediate filament proteins like Neurofilament (neurons) and 
glial fibrillaracidic protein (GFAP) (astrocytes) (Dahlstrand et al., 1995). 
 TUBβ3 is a class III specific β tubulin peculiar for neuronal cells expressed 
both in immature and mature neurons (including cells committed to a 
neuronal fate that are just post mitotic) (Zahir et al., 2009). TUBβ3 
contributes to microtubule stability and has an important role in neuronal 
architecture formation and maintenance, neurite outgrowth, axon 
guidance and axonal transport (Tischfield et al., 2010). 
 MAP2 is expressed mainly in neurons, but has also been detected in some 
non-neuronal cells such as oligodendrocytes and astrocytes. Its 
expression is very weak in neuronal precursors and then becomes strong 
after the expression of neuron-specific TUBβ3. MAP2 has a microtubule 
stabilizing activity and regulates microtubule networks in the axons and  
especially in the dendrites, determining their shape during neuron 
development. Moreover, MAP2 interacts with filamentous actin exerting 
a critical role in neurite initiation, during which networks of microtubules 
and filamentous actin are reorganized in a coordinated manner (Dehmelt 
et al., 2005). 
 Vesicle associated membrane protein 7 (VAMP7) is a SNARE protein 
implicated in neurite elongation (Martinez-Arca et al., 2001). Indeed, 
VAMP7 is associated to vesicles involved in the transport of lipids and 
proteins from the Golgi apparatus to the extensions of plasma membrane 
generating neurites. One out of proteins carried by VAMP7-vescicles is 
neuronal L1CAM; since this protein is transported at the protruding sites 
of plasma membrane and exposed at the neuronal surfaces, it 
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homophilically binds to other L1 molecules from the adjacent cell 
membranes, thus stimulating neurite outgrowth (Alberts et al., 2003). 
 
 
Figure 19. Appearance of neuronal markers during development. Nestin is highly 
expressed in neural progenitors cells, therefore in cells able to differentiate into neurons, 
oligodendrocytes or astrocytes. After neuronal commitment, Nestin expression decreases 
while neuron-restricted progenitor cells begin to express TUBβ3 and MAP2. During 
neuronal maturation, VAMP7 and L1CAM are also expressed.  
 
1.6.4 STEM CELLS CULTIVATED ONTO CNT-BASED SCAFFOLDS 
 
A number of scaffolds have been suggested to control cell adhesion, migration, 
proliferation, and differentiation for tissue engineering. Despite the unique 
abilities of cell patterning techniques, there are still some limitations in creating 
three-dimensional structures able to properly mimic ECM. Recently, a variety of 
nanomaterials including nanoparticles, CNTs, nanofibers and nanoscale-
substrates have been developed to efficiently control dynamic cellular behaviour 
such as cell growth, migration and differentiation. 
Indeed, it has been shown that both embryonic, mesenchymal and neural stem 
cells cultivated onto CNT-based scaffolds acquire the commitment towards 
neurogenesis when coupled with chemical soluble factors. Jan et al., in 2007 
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showed that mouse NSCs - when cultivated in differentiating medium - can then 
successfully differentiate into neurons, astrocytes, and oligodendrocytes with 
clear formation of neurites onto SWNT films. Chao et al., in 2010 showed that 
hESCs seeded onto a Poly(methacrylic acid)-grafted CNT scaffolds and treated 
with laminin are induced to express the neuron specific markers TUBß3 and 
Synapsin I while staminality marker Oct4 is decreased. Chen et al., in 2012 
obtained almost the same results by seeding hESCs onto a silk-CNT composite 
coated with laminin: increased expression of Nestin and TUBß3 and enhanced 
axonal length demonstrated that hESCs differentiate in the presence of CNT 
better than onto silk-only composites or poly-L-ornithine coated coverslips. Kim 
et al., in 2012 showed that neuronal differentiation of human hMSCs cultivated 
in a neurogenic medium can be improved when seeding cells onto CNT sheets. 
Further works showed that stem cells can achieve neuronal commitment either 
in the absence of neuronal stimulating conditions: e.g., Shridharan et al., in 2009 
cultivated hESCs onto a collagen/CNT matrix in the absence of inducing medium 
and showed that cell differentiation occurs toward the ectodermal lineage, as 
suggested by the strong expression of Nestin. Tay et al., in 2010 demonstrated 
that MSCs preferentially adhere in SWCNT covered coverlips respect to naked 
ones and cells showed a transient expression of Nestin and MAP2 genes while no 
upregulation of osteogenic markers were revealed, showing for the first time 
than the only CNT nanoroughness is of use to promote neuronal differentiation. 
Moreover, Chen et al., in 2013 showed that carboxylated MWCNT films 
deposited onto a collagen coated dish promotes hMSC neural differentiation 
through the upregulation of neural growth factors and trapping these neural 
growth factors to create a suitable environment for long-term neural 
differentiation. Furthermore, also Lee et al., in 2014 showed that CNT-collagen 
three dimensional cultures of rat MSCs promotes the expression of neural 
phenotypes and secretion of neurotrophic factors.  
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1.7 SH-SY5Y CELL LINE 
 
SH-SY5Y cell line is a human catecholaminergic neuroblastoma derived from a 
thrice cloned subline SK-N-SH cells, which were originally established from a 
bone marrow biopsy of a neuroblastoma patient in the early 1970’s. SH-SY5Y 
cells resembles immature neuroblasts in culture and are typically locked in an 
early neuronal differentiation stage, biochemically characterized by low presence 
of neuronal markers (Lopes et al., 2010). However, SH-SY5Y cells are able to 
acquire neuron-like phenotypes with neurite outgrowth and branches upon 
treatment with a variety of agents, including all-trans-retinoic acid (RA), phorbol 
ester, 12-O-tetradecanoylphorbol-13-acetate (TPA), BDNF, dibutyryl cyclic AMP 
(dBcAMP), purine, or staurosporine (Xie et al., 2010). The most widely used 
differentiating method is the treatment with RA which is an active metabolite of 
vitamin A. RA functions by binding to two families of nuclear receptors: the RA 
receptors (RARs) family (RARa, b and g), and the retinoid X receptors (RXRs) 
family (RXRa, b and g). Activated RAR heterodimerizes with RXR, then binding of 
RAR/RXR heterodimers to RA response element (RARE) results in transcriptional 
activation (Joshi et al., 2006). Indeed, RA treatment of SH-SY5Y cells stimulates 
the neurite outgrowth and a progressive length increase (depending on time of 
exposure); moreover, it also promotes the synthesis of neurospecific enzymes, 
neurotransmitters, changes in cytoskeletal markers and electrophysiologic 
modifications, as seen in normal neurons (Costantinescu et al., 2007). Therefore, 
SH-SY5Y share many biochemical and functional properties with neurons, hence 
representing a model system of special help in studying molecular mechanisms 
underlying neuronal differentiation. RA treatment also induces the expression of 
TRKB, which is the high affinity catalytic receptor for several neurotrophins, 
including BDNF. BDNF binding to TRKB activates pathways controlling cell 
differentiation (Edsjö et al., 2003). RA also plays a role in regulating transition 
from the proliferating precursor cell to post-mitotic differentiated cell; indeed, 
after in vitro treatment with RA, SH-SY5Y cells arrest in the G1-phase of the cell 
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cycle, DNA synthesis is inhibited and growth inhibition is detected 48 h after 
treatment (Costantinescu et al., 2007). 
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2. AIM OF THE PROJECT 
 
Neural regeneration is a complex mechanism that can be aided by scaffolds able 
to recapitulate the features of the native tissue environment. The purpose of my 
thesis work has been to design and test scaffolds incorporating multiple cues in 
order to provide cells with information important for their growth and 
differentiation. In particular, my PhD project followed two main steps:  
 
1) DEVELOPMENT OF THE BIOMIMETIC SYSTEM: 
 Designing a freestanding scaffold made of carbon nanotubes (CNTs) 
dispersed in a poly-L-lactic (PLLA) matrix and testing its ability to support 
SH-SY5Y cell adhesion growth and differentiation; 
 Designing peptides derived from specific L1 and LINGO1 motifs and 
testing their ability to induce SH-SY5Y differentiation; 
 Combining scaffolds and peptides to further improve cell differentiation. 
 
2) IMPROVEMENT OF THE BIOMIMETIC SYSTEM: 
 Electrospinning of the CNT-PLLA matrix to further mimic neuronal 
extracellular environment; 
 Mutagenesis of specific peptide amino acid residues for a preliminary 
characterization of their mechanism of action; 
 Testing scaffolds and peptides with human circulating multipotent cells 
(hCMCs) in order to use a cell populations suitable for regenerative 
medicine applications and to evaluate if scaffolds and peptides are able 
to induce such stem population to differentiate toward the neuronal 
lineage. 
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3. METHODS 
 
3.1 SCAFFOLD PREPARATION AND CHARACTERIZATION 
 
3.1.1 CNT-PLLA SCAFFOLD 
 
Commercially available MWCNTs (Sigma) were purified by two-steps treatment 
at high temperature, dispersion in aqueous HCl (37%), sonication and membrane 
filtration. MWCNTs were methoxyphenyl (PhOMe)-functionalized and dissolved 
with PLLA in chloroform under mild sonication. The resulting dispersion was 
drop-cast onto a glass dish to obtain the MWCNT-PhOMe@PLLA 1% scaffold. 
MWCNTs were characterized by micro-Raman spectroscopy, thermogravimetric 
analyses (TGA) and differential scanning calorimetry (DSC) analyses. Electrical 
resistance of the CNT-PLLA composite was measured by using a digital 
multimeter. For full methods, see Scapin et al, 2014.  
 
3.1.2 ELECTROSPUN CNT-PLLA SCAFFOLD 
 
The electrospun-CNT-PLLA (eCNT-PLLA) scaffolds were prepared using the same 
CNT-PLLA scaffold solution and processed with the electrospinning technique. 
Electrospinning was performed by passing the solution through an 18G needle at 
a flow rate of 0.03 ml/min, and applying an acceleration voltage of 18 kV, where 
a positive charge was applied to the solution, and the collector was electrically 
grounded at a working distance of 14 cm. The electrospinner was set up such 
that the needle was oriented vertically, and the fibre collector was placed 
directly underneath the needle. Fibres were collected onto 13 mm diameter 
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glass coverslips deposited onto a paper. The process was carried out at room 
temperature within a range of relative humidity (RH = 45–50 %).  
 
All scaffolds were synthesized and characterized by prof. Menna group 
(Department of Chemical Sciences University of Padua). 
 
3.2 PEPTIDE SYNTHESIS AND CHARACTERIZATION 
 
LINGO1-A (467SAKSNGRLTVFPDG480), scrambled LINGO1-A_scr 
(TVFSRSKPLGNDGA), L1-A (178HIKQDERVTMGQNG191), scrambled L1-A_scr 
(IVDQGNREMGTKHQ), L1-A R184A (HIKQDEAVTMGQNG) and L1-A R 184Q 
(HIKQDEQVTMGQNG) peptides, and N-terminally fluoresceinated derivatives of 
L1-A and LINGO1-A were synthesized by the solid-phase method, purified to 
homogeneity (>98%) by reversed-phase high-performance liquid 
chromatography (RP-HPLC) and characterized by high-resolution mass 
spectrometry. The conformation of the peptides was analyzed by circular 
dichroism (CD) on a Jasco J-810 spectropolarimeter, equipped with a Peltier 
temperature control system. For full methods, see Scapin et al, 2014 
 
All peptides were synthesized and characterized by prof. De Filippis group 
(Department of Pharmaceutical and Pharmacological Sciences University of 
Padua). 
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3.3 CELL CULTURE, DIFFERENTIATION AND EXPERIMENTAL 
DESIGN 
 
3.3.1 SH-SY5Y 
 
Exponential growing human neuroblastoma SH-SY5Y cells (Ross et al., 1983), 
were cultured with Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12 
(DMEM/F-12) GlutaMAX™ supplement (Invitrogen) supplemented with 10% 
heat-inactivated foetal bovine serum (FBS, Euroclone) and 25μg/ml gentamicin 
(Sigma) (growth medium), in humidified atmosphere of 5% of CO2 in air at 37 °C. 
Cultures were maintained by subculturing 900000 cells into 25 cm² flasks 
(Sarstedt) every 2 days (once they reached 90% confluence). Cell differentiation 
was induced by treating cells with all-trans-retinoic acid (RA, Sigma) at 10 M 
concentration and lowering the FBS in the culture medium to 2% (differentiation 
medium) 24 h after seeding. In undifferentiated control samples, Dimethyl 
sulfoxide (DMSO) was added as equivalent amount (in which RA is dissolved). In 
experiments with peptides added to culture medium, cells were seeded in a 24-
well plate (15000 cells/well) coated with gelatine (Sigma, porcine skin 0.005% in 
H2O milliQ)/poly-L-lysine (Invitrogen, 1g/ml) solution. 24h after cell seeding 
(day 0), the growth medium was replaced by the differentiation medium; then, 
24h after RA induction (day 1) peptides were added to the culture medium to 
asses if they can influence cell viability/proliferation and promote/inhibit neurite 
elongation. Peptides are not present in control samples. Cell viability and 
proliferation were assessed at all time points (days 0, 1, 2), while neurite lengths 
were measured 24 h after the peptides addition (day 2). In experiments with 
peptides adsorbed onto the substrate, peptides dissolved in gelatine solution 
were adsorbed onto the bottom of a 24-well plate prior to cell seeding (15000 
cells/well). Culture wells coated with poly-L-lysine were used as control. 24 h 
after cell seeding (day 0), the growth medium was replaced by the differentiation 
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medium. Cell viability and proliferation were assessed at three time points (days 
0, 1 and 4) or four time points (days 0, 1, 4 and 7) while neurite lengths were 
measured at day 4. In order to determine the percentage of adsorbed peptides, 
the fluorescein isothiocyanate (FITC)-conjugated version of peptides were used 
to coat well bottoms. Briefly, peptides were dissolved in a gelatine solution and 
incubated in a 24-well plate; then the fluorescence was measured with a plate 
reader (Ascent Fluoroscan, excitation 485 nm, emission 538 nm). Three hours 
after incubation, wells were washed 2 times with PBS and fluorescence was 
measured again in order to calculate the percentage of peptides adsorbed onto 
the wells. In experiments with cells seeded onto the scaffolds, PLLA and CNT-
PLLA sheets were cut into round slices with 13 mm diameter to be well suited for 
positioning in 24-well plates. After sterilization by UV irradiation, PLLA and CNT-
PLLA scaffolds were incubated for 3h with FBS and then cells (15000/well) were 
seeded onto their surfaces. 24 h after cell seeding (day 0), the growth medium 
was replaced with differentiation medium. Culture wells coated with poly-L-
lysine were used as control. Cell distribution (between scaffold and well bottom) 
analysis was performed at day 0, cell viability and proliferation were assessed at 
days 0 and 2 and neurite lengths were measured at day 2. In experiments with 
cells growing onto CNT-PLLA scaffolds and treated with peptides, the CNT-PLLA 
scaffolds were incubated for 3 h with FBS and then cells (15000/well) were 
seeded on their surfaces. 24 h after cell seeding (day 0), the growth medium was 
replaced with differentiation medium and 24 h after RA induction (day 1) the 
peptides (1M L1-A or LINGO1-A) were added to culture medium. Culture wells 
coated with poly-L-lysine were used as control. Cell viability and proliferation 
were assessed at days 0, 1 and 2, while neurite lengths were measured at day 2. 
In experiments with cells seeded onto the electrospun scaffolds, fibre covered 
coverslips were removed from the paper support to be well suited for 
positioning in 24-well plates. After sterilization by UV irradiation, ePLLA and 
eCNT-PLLA scaffolds were incubated for 3h with FBS and then cells (15000/well) 
were seeded onto their surfaces. 24 h after cell seeding (day 0), the growth 
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medium was replaced with differentiation medium. Culture wells coated with 
poly-L-lysine were used as control. Cell distribution (between scaffold and well 
bottom) analysis was performed at day 0, cell viability and proliferation were 
assessed at days 0 and 2 and neurite lengths were measured at day 2. 
 
3.3.2 HUMAN CIRCULATING MULTIPOTENT CELLS (ɦCMCS) 
 
hCMCs were isolated by ficoll density gradient separation from human donor 
peripheral blood and gently provided by prof. Di Liddo group (Department of 
Pharmaceutical and Pharmacological Sciences University of Padua). In 
experiments with cells seeded onto the scaffolds, CNT-PLLA sheets were cut into 
round slices with 13 mm diameter to be well suited for positioning in 24-well 
plates. After sterilization by UV irradiation, CNT-PLLA scaffolds were incubated 
for 24h in the culture medium. Then cells (12000/well) were seeded onto 
scaffold surfaces in complete growth medium (DMEM/F12 supplemented with 
16.5% of heat-inactivated FBS and 50 U/ml penicillin - 50 g/ml streptomycin). 
Cells were maintained in humidified atmosphere of 5% of CO2 in air at 37 °C. 24 
h after cell seeding (day 1), the growth medium was replaced with differentiation 
medium (DMEM/F12 supplemented with 2% of heat-inactivated FBS, 50 U/ml 
penicillin - 50 g/ml streptomycin and RA 10 M). In undifferentiated control 
samples, DMSO was added as equivalent amount (in which RA is dissolved). Cells 
were maintained in culture for five days after cell seeding and analyses were 
performed at the following time points: cell proliferation, days 1, 3 and 5; 
morphological observations, day 1; qPCR experiments, days 1, 3 and 5; 
immunofluorecence, day5. In experiments with peptides added to culture 
medium, cells were seeded in 24-well plates (12000 cells/well) in complete 
growth medium. 24h after cell seeding (day 1), the growth medium was replaced 
by the differentiation medium; then, 24h after RA induction and the lowering of 
FBS (day 2) peptides (1 M concentration) were added to the culture medium to 
asses if they can influence cell proliferation and differentiation. Peptides are not 
 60 
 
present in control samples. Cell proliferation was assessed at days 1, 3 and 5 
while qPCR experiments were performed at day 3 and 5. In experiments with 
cells seeded onto the eCNT-PLLA scaffolds, fibre covered coverslips were 
removed from the paper support to be well suited for positioning in 24-well 
plates. After sterilization by UV irradiation, eCNT-PLLA scaffolds were incubated 
for 24h in the culture medium. Then cells (12000/well) were seeded onto 
scaffold surfaces in complete growth medium. 24 h after cell seeding (day 1), the 
FBS concentration was reduced to 2%. Morphological observations and qPCR 
analyses were performed at day 1. 
 
3.4 ANALYSIS OF CELL VIABILITY/PROLIFERATION AND 
NEURONAL DIFFERENTIATION 
 
3.4.1 CELL PROLIFERATION 
 
Resazurin reduction assay was performed to quantify the metabolically active 
living cells and thus to monitor how do peptides and the scaffolds affect cell 
proliferation of the cell populations tested. The assay is based on reduction of 
the indicator dye, resazurin (not fluorescent), to the highly fluorescent resorufin 
(excitation 569 nm, emission 590 nm) by viable cells. Non-viable cells rapidly lose 
their metabolic capacity to reduce resazurin and, thus, do not produce 
fluorescent signals anymore. Briefly, the culture medium was substituted with 
500 L of resazurin solution (Resazurin Sigma 15 μg/mL in complete medium 
without phenol red) and cells were incubated for 4 h in dark at 37°C and 5% CO2. 
Then, 200 μL of resazurin solution were removed twice from each well and 
transfer to a 96 well plate (technical duplicates). Fluorescence, directly 
correlated with cell quantity, was read in a plate reader (Ascent Fluoroscan, 
excitation 540 nm, emission 590 nm). Background values from wells without cells 
were subtracted and average values for the duplicates calculated. Cell 
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proliferation was calculated from a calibration curve by linear regression using 
Microsoft Excel. Resazurin assay was also used for testing cell ability to adhere to 
the scaffolds. 24 h after cell seeding, scaffolds were removed from the original 
wells and positioned into clean ones. Both wells were incubated with resazurin 
solution to quantify the number of cells adherent to scaffold or to well bottom.  
 
3.4.2 CELL VIABILITY 
 
The CytoTox-ONE™ Homogeneous Membrane Integrity Assay (Promega) was 
used to quantify the lactate dehydrogenase (LDH) release by cells that lose 
membrane integrity. Briefly, 100 μL of culture medium were transferred to a new 
96 well plate. 50 μL of the reaction solution from the kit, containing the 
detection dye and the catalyst were then added to culture supernatants and 
fluorescence was measured after 10 minutes in a plate reader (Ascent 
Fluoroscan, excitation 540 nm, emission 590 nm). Background values from wells 
without cells were subtracted and average values for the duplicates calculated. 
Cell death was calculated from a calibration curve by linear regression after 100% 
cell lysis of known cell quantities. Cytotoxicity was then calculated according to 
the following equation: Cytotoxicity (%) = (number of dead cells)/(number of 
dead cells + number of living cells) x100.  
 
3.4.3 NEURITE LENGTH ANALYSIS (SH-SY5Y CELLS) 
 
Neurite outgrowth was measured after staining the cells with calcein 
acetoxymethyl ester (Calcein-AM, Biotium), a non-fluorescent cell permeable 
compound that when hydrolyzed by intracellular esterases in live cells converts 
to the strongly green fluorescent calcein (excitation 490 nm, emission 539 nm). 
This staining is particularly useful to clearly detect, along their whole length, the 
neural processes and to visualize cells growing onto the black CNT-PLLA 
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scaffolds. Briefly, cells were incubated with calcein-AM (2 M in HBSS, Hank's 
Balanced Salt Solution, Invitrogen) for 30 minutes in dark at 37°C and 5% CO2 
and visualized under a fluorescent microscope (Leica DM4000b) using green 
fluorescent protein (GFP) filter. Each experiment was performed in duplicate 
(two wells per conditions). Five images/well were recorded (ten images for each 
condition), taken with a 20X objective. The first field was set to correspond to 
the centre of the well. Next fields were then selected following each of the four 
directions (N, S, W, E) from the first field. Neurite length was measured using LAS 
AF lite software (Leica) by tracing the trajectory of the neurite from the tip to the 
junction between the neurite and cell body. If a neurite exhibited branching, the 
measure from the end of the longest branch to the soma was recorded, then 
each branch was measured from the tip of the neurite to the neurite branch 
point. The neuritogenic properties were analyzed in terms of total neurite 
length/no. of cells (aggregate length of all cellular processes divided by cell 
number), no. of neurites/no. of cells, no. of branch points/no. of neurites, the 
percent of neurites longer than 100 m, no. of growth cones/no. of cells. Only 
neurites longer than 50 m were considered (Hu et al., 2004; Munnamalai et al., 
2014). 
 
3.4.4 ɦCMC MORPHOLOGICAL ANALYSES 
 
Cells were stained with Calcein-AM and inspected under the Leica DM 4000b 
inverted microscope equipped with the GFP filter. Five images/well were 
recorded (ten images for each condition), taken with a 20X objective. Field 
selection was performed as reported above. The morphological analyses 
performed are: no. of polarized cell/no. of cells, total protrusion length/no. of 
cells, no. of protrusions/no. of cells, total diameter length/no. of cells. The length 
of each neurite-like protrusion was measured from the cell body edge to the tip 
of the protrusion. Any protrusion shorter than half the cell body diameter was 
not recognized as a neurite-like protrusion and therefore cells were not 
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considered as polarized (Huang et al., 2013). Cell diameter was considered as the 
longest distance between two edges in the cell body (major axis). Protrusion 
length and diameter were measured using LAS AF lite software (Leica). 
 
3.4.5 SCANNING ELECTRON MICROSCOPY ANALYSIS 
 
The morphology of eCNT-PLLA scaffold fibres was studied by scanning electron 
microscopy (SEM); eCNT-PLLA scaffolds were coated with a thin film of gold 
particles to improve scaffold conductivity. For the analysis of SH-SY5Y cells 
growing onto CNT-PLLA scaffolds, cells were fixed in 4% paraformaldehyde in 
phosphate buffered saline (PBS), dehydrated in solutions with increasing ethanol 
concentration, and air dried. Samples were then coated with a thin layer of gold 
particles and examined and photographed using a Jeol JSM-6490 SEM.  
 
3.4.6 RNA EXTRACTION AND RETROTRANSCRIPTION 
 
RNA from each sample was obtained after cell homogenization with TrizolTM 
reagent (Invitrogen), following the manufacturer’s instructions. After complete 
dissociation of nucleoprotein complexes, phase separation was achieved with 
chloroform and centrifugation at 12000 g. RNA was precipitated from the 
aqueous phase with isopropanol and washed with 70% ethanol. The RNA was 
dried and dissolved in RNase-free water. RNA was retrotranscribed in cDNA using 
GoScriptTM Reverse Transcription System and oligo(dT) primers (Promega). 
Briefly, 4 l of RNA were incubated with oligo(dT) primers for 5 minutes at 70 °C 
for allowing template denaturation and than chilled for 5 minutes in ice. Then, 
the RNA and the oligo(dT) primers were added to 15 l of mix solution containing 
the GoScriptTM reverse transcriptase, MgCl2, PCR nucleotide mix, buffer and the 
ribonuclease inhibitor. Such reaction mix was then incubated for 5 minutes at 
25°C (annealing), 60 minutes at 40°C (extension) and 15 minutes at 70°C 
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(retrotranscriptase inactivation). After retrotranscription, the integrity of cDNA 
was checked by control PCR (Polymerase Chain Reaction). The S13 gene was 
amplified as an housekeeping internal control. 
 
3.4.7 REAL TIME RT-PCR (qPCR) 
 
Gene expression was analyzed by two-step real-time RT-PCR. 1l of cDNA was 
used for each qPCR reaction that was performed using Power SYBR® Green PCR 
Master Mix (Life technologies) in a final reaction volume of 20 µl. The thermal 
cycler (Rotor-Gene 3000 from Corbett Research) was set as follows: 9’ at 95°C 
followed by 43 cycles consisting of 30” melting at 95°C + 30” annealing at 60°C + 
35” extension at 72°C. All primers were tested for their amplification efficiency: 
the threshold cycle (CT) values of four cDNA dilutions were plotted against the 
logarithm of input amount of standard material, in order to generate a standard 
curve. Only those primers having comparable value of the slope were 
considered. At least three independent experiments were performed in 
triplicate, each qPCR reaction was run in duplicate (technical replicates) and each 
gene was run together with its own reference gene and a negative control. The 
gene encoding human ribosomal protein S13 was used as the housekeeping 
control for normalization (Vacca et al., 2011). The comparative CT method (2-
ΔCᵀ) was used to quantify gene expression. Melting curve analysis was 
performed to ensure all transcripts under investigation would be represented by 
a single peak, as an index for specificity (melting ramp from 70 to 95°C). Data 
analysis was carried out using the Rotor-Gene software (version 6.1; Corbett). 
The following forward (F) and reverse(R) primers (SIGMA-Genosys) were used: 
 
S13-F: 5’-TACAAACTGGCCAAGAAGGG-3';  
S13-R: 5'-GGTGAATCCGGCTCTCTATTAG-3'; 
Nestin-F:5’-CAGGGGAGGACTAGGAAAAGA-3’; 
Nestin-R: 5’- GAGATGGAGCAGGCAAGAG-3’; 
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TUBß3-F: 5’- AGGAAGAGGGCGAGATGTA-3’; 
TUBß3-R: 5’- CAATAAGACAGAGACAGGAGCAG-3’; 
MAP2-F: 5’- ATAGACCTAAGCCATGTG-3’; 
MAP2-R: 5’ -GGGACTGTGTAATGATCTC-3’; 
TRKB-F: 5‘-TAGATCCTGAGAACATCACCG-3’; 
TRKB-R: 5‘-GGATCAGTTCAGACAAGTCAA-3’; 
VAMP7-F: 5’-CACTGATGATGATTTTGAACG-3’; 
VAMP7-R: 5’-CTGAGCTACCAGATCTATGTTTCT-3’; 
L1 (neuronal)-F: 5’ CCCTGGAGAGTGACAACG-3’; 
L1 (neuronal)-R: 5’ CCTGGACTCCACTATTCTAGGG-3’; 
LINGO1-F: 5’ TGGTGCTGCTGTTTCTCTG-3’; 
LINGO1-R: 5’ CGTGTGTAGAAGGGTAGGGA-3’. 
 
3.4.8 IMMUNOFLUORESCENCE 
 
Five days after seeding, hCMCs were rinsed three times with PBS and then fixed 
with BD Cytofix™ Fixation Buffer (BD Biosciences) for 20 min at 4°C. hCMCs were 
then rinsed three times with PBS, permeabilized with 0.2% Triton in PBS for 30 
min at room temperature and incubated in blocking solution (5% FBS in PBS) for 
30 min at room temperature. hCMCs were then incubated for 1 hour at room 
temperature with primary antibodies diluted in blocking solution. Mouse anti-
neuron specific β-III tubulin (1:200, MAB 1637 Millipore) was used as primary 
antibody. After 3 washes in PBS, cells were incubated for 1 hour at room 
temperature with secondary donkey anti-mouse antibody conjugated with Alexa 
Fluor-488 (Life technologies) at a 1:300 dilution. Nuclei were counterstained 
using Hoechst 33258 (Life technologies) for 5 min, and then washed three times 
with PBS. A small amount of PBS was left to keep well surfaces wet hence to 
avoid monolayer drying. Samples were inspected under the Leica DM 4000b 
inverted fluorescent microscope using the GFP (TUBβ3) and A4 (nuclei) filters. 
TUBβ3 and nuclei images were overlapped using LAS AF lite software (Leica). 
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3.5 BIOINFORMATIC ANALYSES 
 
3.5.1 HOMOLOGY SEARCHES AND STRUCTURAL MODELING 
 
Fold recognition searches were performed using Phyre 2 (Kelley et al., 2009), 
structural models were obtained by homology modeling using the Swiss model 
server (Guex et al., 1997). Structural superposition and analyses were performed 
using USFC Chimera software (Pettersen et al., 2004). Proteome-wide search for 
orthologous sequences of the L1 Ig2 and LINGO1 Ig domains were performed 
using corresponding sequences from the human proteins as probes for blastp 
runs at the blast NCBI server, using default settings, database limitation set to 
UniprotKB, taxonomic limitation set to Metazoa and excluding fragments 
(incomplete sequences). 
 
3.5.2 PRIMER DESIGN 
 
Each primer pair consists of specific forward and reverse primers derived from 
gene sequences contained in the NCBI Reference Sequence database. They were 
designed in order to produce a 250 bp amplicon crossing exon/exon boundaries 
whenever possible, to enable amplification of cDNA sequences and to prevent 
coamplification of genomic DNA. They all are standardized to work at the same 
temperature (60°C). L1 primers were designed to be specific for the L1 neuronal 
splicing isoform. Melting temperatures of PCR primers and possible occurrence 
of hairpins, self- and hetero-dimers was ruled out by Oligoanalyzer 3.1 
(http://eu.idtdna.com/calc/analyzer) and the specificity was checked with 
primer-BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast/). 
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3.6 STATISTICAL ANALYSES 
 
Statistical analysis was performed using paired Student’s t test, and results were 
considered significant when p< 0.05. Values are expressed as mean ± standard 
error of the mean (M ± SEM). 
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4. RESULTS 
 
4.1 SET UP AND VALIDATION OF A POLYMER-CNT SCAFFOLD 
 
Dispersion of CNTs into a biocompatible polymer matrix can help to generate a 
freestanding and implantable device (Gheith et al., 2005). Combination of a 
biocompatible polymer and a conductive nanostructure is expected to boost 
neuronal growth/differentiation by coupling polymer features (biocompatibility, 
processability, low cost, implantability) and CNT properties (mimicking of the 
topography of neural environment and conductivity). We chose PLLA as polymer 
matrix because of its biocompatibility and employment for neural tissue 
engineering applications (Yang et al., 2004; Koh et al., 2008; Gertz et al., 2010). 
Among the plethora of available CNTs, we chose MWCNTs because of high 
conductivity and shape mimicking nanoscale features of the extracellular matrix. 
We purified commercial MWCNTs to remove heavy metal impurities, which may 
result cytotoxic (Furtado et al., 2004). Moreover, to improve dispersibility, we 
functionalized the MWCNTs through addition of the diazonium salt of 4-
methoxyaniline (Salice at al., 2012; Salice et al., 2014). We determined, according 
to a previously reported approach (D’Este et al., 2006), a degree of 
functionalization (see supplementary file) of 1/97. Characterization of MWCNTs 
by TGA analysis and micro-Raman spectroscopy is shown in Fig. 20. The resulting 
CNT derivatives, soluble in chloroform, were used to prepare a polymer 
nanocomposite made of 1% w/w MWCNTs dispersed into a PLLA matrix by 
solvent evaporation (Fig. 20C). Raman spectroscopy, TGA and DSC confirmed 
CNTs to be well dispersed in the scaffold (Fig. 20D-E-F). The electrical resistivity 
of the nanocomposite scaffold is around 130 kΩ with respect to >2000 kΩ of the 
pristine PLLA; in addition, it shows features compatible with a free-standing 
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polymer film as required for implantable scaffolds. Indeed, we compared CNT-
PLLA and PLLA scaffolds for both biocompatibility and neuritogenic properties. 
Calcein-AM staining revealed that SH-SY5Y cells can adhere and grow onto both 
CNT-PLLA and PLLA scaffolds and show homogeneous spreading (Fig. 21A). No 
difference in cell proliferation (Fig. 21B) and viability (Table 1) was observed 
when growing cells onto either poly-L-lysine or the scaffolds; however, as shown 
in Fig. 21C, cells better adhere to CNT-PLLA (~63%) than to PLLA alone (~39%). 
Furthermore, cells grown onto CNT-PLLA can be differentiated with RA as well as 
control samples and they present a total neurite length higher than samples 
grown onto PLLA (Fig. 21D). SEM images of cells cultured onto CNT-PLLA show a 
healthy morphology and the outgrowth of neurites attaching to the scaffold 
surface (Fig. 22). At high magnifications, the intimate contacts between the 
scaffold and neuronal membrane are evident (Fig. 22D). Furthermore, when 
compared to control cell cultures (poly-L-lysine substrate), cells grown onto CNT-
PLLA show an increased number of long filopodia extending from the growth 
cone and making contacts with the scaffold, possibly depending on improved 
activity of growth cones in sensing topographical cues (Fig. 22G). 
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Figure 20. Scaffold characterization. TGA and micro-Raman analysis of MWCNT-
PhOMe: Thermogram representing the residual weight (continuous line) and the weight 
loss derivative (dashed line) of the MWCNT-PhOMe measured under nitrogen 
atmosphere with a 10°C/min heating ramp (A). Micro-Raman spectrum of the MWCNT-
PhOMe sample (excitation line: 633 nm) (B). CNT-PLLA scaffold characterization: 
Photograph of the PLLA@MWCNT-PhOMe 1% film (C). FT-Raman spectrum of the 
PLLA@MWCNT-PhOMe 1% film (excitation line: 633 nm) (D).Thermogram representing 
the residual weight (dashed line) and the weight loss derivative (continuous line) of the 
PLLA@MWCNT-PhOMe 1% film measured under nitrogen atmosphere with a 10°C/min 
heating ramp (E). Differential scanning calorimetry (DSC) curve of the PLLA@MWCNT-
PhOMe 1% film measured under nitrogen atmosphere with a 10 °C/min heating ramp (F) 
(Scapin et al., 2014). 
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Figure 21. CNT-PLLA scaffold effect on SH-SY5Y cell adhesion, growth and 
differentiation. SH-SY5Y cells stained with Calcein-AM. Image magnification is reported 
(A). Cell proliferation (B), distribution (C) and differentiation (D). Data represent the 
mean ± SEM of three independent experiments performed in duplicate. *shows 
significance at p<0.05 between cells seeded onto CNT-PLLA and PLLA. (Scapin et al., 
2014). 
 
 
Table 1. Percentage of cell death relative to three independent experiments performed in 
duplicate. * shows significance at p<0.05 between samples grown onto scaffolds and 
control cells (grown onto Poly-L-lysine).  
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Figure 22. SH-SY5Y morphology when grown onto the CNT-PLLA scaffold. 
(A to F) Scanning electron microscopy images of SH-SY5Y cells grown onto CNT-PLLA 
scaffolds. Scale bar: A, C, E, F = 50 m; B = 10 m; D = 5 m. Panels B and D show details 
of the framed area in A and C, respectively. (B, F) Outgrowth of neurites attaching to the 
scaffold surface. At higher magnification (D) the intimate contacts between CNT-PLLA 
scaffolds and neuronal membrane are evident. (E) Growth cone morphology of cells 
growing onto the scaffolds. (G) Typical growth cones observed when cell differentiation is 
induced with RA. Cells were stained with calcein-AM. Image magnification is 32X (Scapin 
et al., 2014). 
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4.2 THE NEURITOGENIC PEPTIDES 
4.2.1 IDENTIFICATION OF PEPTIDES DERIVED FROM L1 AND LINGO1 
 
Cellular differentiation can be induced by synthetic peptides able to mimic  
differentiation signals. To this aim, peptides should correspond to interaction 
motifs likely to mediate such signals. In order to provide signals driving correct 
neuronal growth and differentiation, we started from the evidence that 
neuritogenesis and process guidance/elongation are driven by CAM proteins 
such as L1 (Alberts et al., 2003). In this work we tested biocompatibility and 
neuritogenicity of two peptides derived from L1 and LINGO1. The Ig2 repeat of 
the L1 ectodomain is involved in the homophilic binding and the interaction 
region corresponds to a 14-aminoacid long peptide named L1-A (Zhao et al., 
1998). Therefore, we reproduced L1-A as a synthetic peptide for our 
experiments. Then, we searched for structural homologues of the L1 Ig2 repeat, 
to find further regulators of neural differentiation by homo/heterophilic 
interactions. Fold recognition search intriguingly identified the single Ig repeat of 
the LINGO1 ectodomain as the best structural template (99.7% confidence, 93% 
coverage). Given that identity between L1 Ig2 and LINGO1 Ig is 29%, we could 
use homology modeling method for obtaining a reliable model. Then, 
superposition (Fig. 23A) of the LINGO1 Ig template (Fig. 23B) and the L1 Ig2 
model (Fig. 23C) revealed high structural similarity (RMSD = 0.65 Å). Intriguingly, 
the L1-A and aligned LINGO1 Ig sequence 467-480 (hereafter referred to as 
LINGO1-A), displayed high similarity. In particular, the two sequences share four 
identical amino acids and eight residues with similar physico-chemical properties 
(Fig. 23D). It has to be stressed that: (i) both LINGO1 and L1 are neural proteins 
involved in neurite outgrowth control, (ii) the LINGO1 Ig structure is quite similar 
to the L1 Ig2 domain, and (iii) the alignment between L1-A and LINGO1-A shows 
high conservation, including aminoacid positions relevant to L1 function (Zhao et 
al., 1998). Therefore, we produced LINGO1-A as synthetic peptide for our 
experiments. In order to distinguish among specific and unspecific effects, we 
 75 
 
also synthesized the scrambled versions of the two peptides (L1-A_scr and 
LINGO1-A_scr). All peptides were produced by solid-phase synthesis and their 
chemical identities established by high-resolution mass spectrometry (Fig. 23E-
F). As expected from both LINGO1-A and L1-A localization in flexible loop regions 
(see structural models in Fig. 23B-C), the conformation of the synthetic peptides 
in solution is essentially disordered as documented by the far-UV CD spectra 
resembling those typical of an unfolded polypeptide chain (Brahms et al., 1980) 
(Fig. 23G-H). Given that (i) L1-A was only investigated about its involvement in 
L1-L1 homophilic interactions (i.e. its role in cellular signaling was not 
determined) (Zhao et al., 1998) and (ii) LINGO1 Ig domain alone both mediates 
homo- and heterophilic interactions (Stein et al., 2012), but its binding region has 
not been identified yet, we decided to test the two peptides using the SH-SY5Y 
cell system to asses if (i) L1-A can trigger neurite elongation and (ii) LINGO1-A can 
regulate neural differentiation as well. 
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Figure 23. L1-A and LINGO1-A identification and characterization. (A) 
Superimposition between LINGO1 Ig domain (Blue) and L1 Ig2 domain (Orange). (B) 
LINGO1-A region (blue) and (C) L1-A region (orange) localization within the LINGO1 Ig 
and L1 Ig2 domains (gray) respectively. Models were obtained by UCSF Chimera software. 
(D) Alignment of L1-A and LINGO1-A peptide sequences. Black (identity), dark gray (same 
amino acid group), gray (compatible amino acid groups), white (different properties). 
Consensus code: c, compatible properties (polar and charged); h, hydrophobic; p, polar; +, 
positively charged. (E, F) RP-HPLC analysis of purified L1-A (E) and LINGO1-A (F) 
peptides by a C18 column eluted with an acetonitrile-0.078% TFA gradient (---) (Inset) 
Deconvoluted ESI-TOF mass spectrum of RP-HPLC purified peptides. The estimated 
molecular masses of L1-A (1611.79 ± 0.02 a.m.u.) and LINGO1-A (1447.72 ± 0.02 a.m.u.) 
peptides is in agreement with the theoretical values: 1611.78 and 1447.74 a.m.u., 
respectively. (G, H) Far-UV circular dichroism spectra of LINGO1-A (G) and L1-A (H) 
derivatives. All spectra were recorded at 25°C in PBS. L1-A and LINGO1-A spectra are in 
black; spectra from the corresponding scrambled peptides are in red. (Scapin et al., 2014). 
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4.2.2 L1-A AND LINGO1-A EFFECTS ON NEURONAL GROWTH AND 
DIFFERENTIATION 
 
4.2.2.1 Peptides in solution 
 
L1-A and LINGO1-A peptides were separately added to the medium at increasing 
peptide concentrations (0, 0.01, 0.1, 1, 10, 100 M) to assess their effect on cell 
viability/proliferation and neuronal differentiation. As shown in Fig. 24A, both 
peptides do not alter cell proliferation with respect to control. Moreover, they 
are not cytotoxic as cell death in samples treated with the peptide is comparable 
to control (Table 2). Then, neuritogenic properties were analyzed and both 
peptides showed the highest effect on total neurite length at 1 M 
concentration (Fig. 24B). In RA treated samples, L1-A addition increases total 
neurite length up to +~96%; in the absence of RA, the highest increase (+~115%) 
is mediated by LINGO1-A. In order to more precisely determine the optimal 
peptide concentration, a second series of experiments was performed narrowing 
dose response curves around 1M peak. Data in Fig. 24C indicate 1 M as the 
optimal concentration for both peptides. Then, the number of neurites per cell 
and the percentage of neurites longer than 100 m were calculated. In order to 
aggregate the two set of experiments, only 0, 0.1, 1, 10 M peptide 
concentrations were considered. Again, dose response curves reveal a bell-
shaped pattern with the highest neuritogenic effect at 1 M concentration (Fig. 
24D-E). The number of neurites per neuron (Fig. 24E) follows the same trend as 
observed for the total neurite length: the highest effect is mediated by L1-A in RA 
induced samples (+~66%) or by LINGO1-A in the absence of RA (+~82%). The 
highest percentages of neurites longer than 100 m (Fig. 24D) is found in 
samples treated with LINGO1-A (+~76%) and LINGO1-A RA (+~72%).  
Given that both peptides mediated significant neuritogenic effects and according 
to established literature (Soroka et al., 2002), their scrambled versions (L1-A_scr 
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and LINGO1-A_scr) were used to discriminate among sequence specific 
mechanisms and effects unspecifically depending on amino acid composition. 
Scrambled peptides, like native ones, did not alter cell proliferation (Fig. 25A). In 
samples treated by scrambled peptides, values for total neurite length, number 
of neurites per neuron and percentage of neurites longer than 100 m are 
comparable, or even lower than control (Fig. 25 B-C-D). Native peptides 
confirmed evidence from previous experiments, as the highest effect on total 
neurite length (Fig. 25B) and number of neurites per cell (Fig. 25C) is mediated by 
L1-A in RA-treated samples (+~88% total neurite length; +~71% neurites per cell) 
and by LINGO1-A in the absence of RA (+~82% total neurite length; +~44% 
neurites per cell). Furthermore, the highest percentage of neurites longer than 
100 m (Fig. 25C) is found in LINGO1-A treated samples (+~60% LINGO1-A, 
+~63% LINGO1-A RA). The neuritogenic effect of LINGO1-A and L1-A used in 
combination is lower than individual peptides. 
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Figure 24. Effect of peptides added to the culture medium on SH-SY5Y cell 
proliferation and differentiation. Proliferation (A), total neurite length (B, C), neurites 
longer than 100 m (D) and neurites per cell (E) from SH-SY5Y cells treated with 
increasing peptide concentrations in the absence or presence of RA. (A) White bars, 
control without peptides; other bars, the darker the colour the higher the peptide 
concentration following this gradient (0.001, 0.1, 1, 10, 100 M). (B to E) Peptide 
concentrations: A, no peptide; B, 10 nM; C, 100 nM; D, 1 M ; E, 10 M; F, 100 M; G, 316 
M; H, 3.16 M. Data represent the mean ± SEM of three (A, B, C) and six (D, E) 
independent experiments performed in duplicate. # shows significance at p<0.05 
between cells treated with peptides and the control without peptides. * shows 
significance at p<0.05 between samples 1X and sample 0.1X. + shows significance at 
p<0.05 between samples treated with L1-A and LINGO1-A at the same concentration. 
(Scapin et al., 2014). 
 
 
Table 2. Percentage of cell death relative to three independent experiments performed in 
duplicate. 
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Figura 25. Effect of scrambled peptides (1 M) added to the culture medium on SH-
SY5Y cell proliferation and differentiation. Proliferation (A), total neurite length (B), 
neurites per cell (C), neurites longer than 100 m (D) and representative microscopy 
fields (E) from SH-SY5Y cells treated with 1 M peptides or their scrambled versions in 
the absence or presence of RA. Data represent the mean ± SEM of three independent 
experiments performed in duplicate. * shows significance at p<0.05 between samples 
treated with peptides and the control without peptides. # shows significance at p<0.05 
between samples treated with peptides and samples treated with their scrambled version. 
SH-SY5Y cells in (E) are stained with Calcein-AM. Image magnification is 20X. (Scapin et 
al., 2014). 
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4.2.2.2 Peptides adsorbed onto the substrate 
 
The two peptides were designed to be used as guidance cues, mimicking 
ectodomains that could be biologically active either in solution or exposed at the 
surface of cells supporting neuronal growth. Therefore, in order to assess 
variation of their effects when used in solution or adsorbed onto a substrate, L1-
A or LINGO1-A (at 1 M or 10 M concentrations) were also used (individually or 
in combination) for coating well bottoms. The residual amount of peptides (prior 
to cell seeding) was found to be approximately 75% (calculated by coating the 
well bottom with the peptide FITC-versions and quantifying the residual 
fluorescent after washing). As shown in Fig. 26A-B, both peptides are confirmed 
to have no meaningful effect on cell proliferation. Similarly, absence of 
cytotoxicity is confirmed (Table 3). When deposited onto the substrate, peptides 
exert a good neuritogenic effect. In fact, in all peptide-treated samples, the total 
neurite length is improved with respect to control samples (Fig. 26C-D) and the 
highest neuritogenic effect is observed at 1 M concentration. Experiments with 
scrambled peptides confirmed the sequence-dependent specificity observed 
with peptides in solution. In particular, no effect is observed on cell proliferation 
(Fig. 27A) and cell death (not shown). Concerning total neurite length, number of 
neurites per neuron and percentage of neurites longer than 100 m, values for 
scrambled peptides are always comparable or lower than control (Fig.27B-C-D). 
Native peptides confirmed their neuritogenic potential as the total neurite length 
(Fig. 27B), the number of neurites per neuron (Fig. 27C) and the percentage of 
neurites longer than 100 m (Fig. 27D) are improved by native peptides. 
Differently from experiments in solution, the effect of the two peptides in 
combination is comparable or higher than individual peptides, while difference 
among L1-A or LINGO1-A treated samples is less evident, possibly because of the 
prolonged culture time (i.e. four days after RA induction). 
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Figure 26. Effect of peptides deposited onto the substrate on SH-SY5Y cell 
proliferation and differentiation. Proliferation (A, B) and total neurite length (C, D) of 
SH-SY5Y cells seeded onto substrates coated with either 1 M (A, C) or 10 M (B, D) 
peptides. Data represent the mean ± SEM of three independent experiments performed 
in duplicate. § shows significance at p<0.05 between samples treated with RA and their 
respective untreated controls. * shows significance at p<0.05 between cells growing onto 
peptide substrate and the control (cells growing on poly-L-lysine). Incremental values 
compared to control are reported. (Scapin et al., 2014). 
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Figure 27.Effect of scrambled peptides (1M) deposited onto the substrate on SH-
SY5Y cell proliferation and differentiation. Proliferation (A) Total neurite length (B) 
neurites per cell (C), neurites longer than 100 m (D) and representative microscopy 
fields (E) from SH-SY5Y cells seeded onto substrates coated with 1 M peptides or their 
scrambled versions in absence or presence of RA. Data represent the mean ± SEM of 
three independent experiments performed in duplicate. * shows significance at p<0.05 
between cells growing onto peptide surface and the control (cells grown onto poly-L-
lysine). # shows significance at p<0.05 between samples growing onto peptide surface 
and samples growing on their respective scrambled version. SH-SY5Y cells in (E) are 
stained with Calcein-AM. Image magnification is 20X. (Scapin et al., 2014). 
Table 3. (A-B) Percentage of cell death relative to three independent experiments 
performed in duplicate. 
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4.3COMBINED EFFECTS OF THE CNT-PLLA SCAFFOLD AND 
NEURITOGENIC PEPTIDES ON NEURONAL GROWTH AND 
DIFFERENTIATION. 
 
Separate characterization provided us with evidence that the CNT-PLLA scaffold 
is well suitable for neuronal culture and the peptides exert specific and 
important neuritogenic effects. Therefore, we performed experiments to 
determine if their combination could further promote neuronal differentiation. 
The scaffold+peptides combination neither altered cell proliferation nor cell 
death (Fig. 28A and Table 4), while showing instead evidence of synergy: total 
neurite length is significantly improved in RA induced samples treated by either 
L1-A or LINGO1-A when cells are grown onto the scaffold (Fig. 28B). Synergistic 
effect is also observed when cells are treated with L1-A in the absence of RA. 
Density of branch points per neurites and of neurites per cells were also 
determined and a synergistic effect is likely to occur as values for peptide and RA 
treated cells grown onto the scaffold are equal or higher than corresponding 
control samples (Fig. 28C-D). Synergistic effect can also be inferred when 
considering growth cone numbers. A growth cone was defined as a fan-shaped 
structure at the tip of a neurite, where the neurite began to increase in width 
(Abney et al., 1999; Dent et al., 2013). When used separately, neither peptides 
nor the scaffolds show meaningful effect (Fig. 28E), but when RA induced cells 
are simultaneously grown onto the scaffold and treated with the peptides, 
growth cone number is considerably increased (+~97% L1-A RA; +~49% LINGO1-A 
RA). 
 
Table 4. Percentage of cell death relative to four independent experiments performed in 
duplicate. 
 85 
 
 
Figure 28. Comparison between SH-SY5Y cells seeded onto the CNT-PLLA scaffold 
(S) and control (poly-L-lysine coated wells) when treated with 1 M peptides in the 
absence or presence of RA. Proliferation (A), total neurite length (B), neurites per cell 
(C), branches per neurite (D), growth cones per cell (E) and representative microscopy 
fields(F). Data represent the mean ± SEM of three independent experiments performed in 
duplicate.*shows significance at p<0.05 between samples treated with peptides and their 
respective control without peptides. § shows significance between samples growing onto 
CNT-PLLA scaffold and control (poly-L-lysine coated wells). SH-SY5Y cells in (F)are stained 
with Calcein-AM. Growth cones are indicated by white arrows. Image magnification is 32X. 
(Scapin et a., 2014) 
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4.4 EFFECTS OF L1-A AND LINGO1-A PEPTIDES ON SH-SY5Y 
GENE EXPRESSION 
 
The L1-A and LINGO1-A peptides showed a positive and specific effect in SH-SY5Y 
cell differentiation, but the understanding of their molecular mechanism of 
action could be of help to properly use them in clinical applications. Quantitative 
PCR analyses were performed in order to test which genes are upregulated after 
peptide administration and hence to get suggestions on the molecular pathway 
activated by the cells. 24 hours from peptide administration, Nestin upregulation 
occurs in samples treated with L1-A either in the presence or in absence of RA 
stimulation (Fig. 29A). Otherwise, TUBβ3 is upregulated in L1-A treated samples 
after RA stimulation and in LINGO1-A treated samples in the absence of RA 
stimulation (Fig. 29B). Effect on MAP2 expression is not so evident, except for a 
significant increase in LINGO1-A treated samples in the absence of RA induction 
(Fig.29C). VAMP7 and TRKB are upregulated both in L1-A and in LINGO1-A 
treated samples, either in presence or in the absence of RA stimulation (Fig. 
29D,E); moreover, TRKB is strongly upregulated by RA treatment (Fig. 29E). 
Interestingly, TRKB is significantly more expressed in LINGO1-A treated samples 
than in L1-A treated samples, in the absence of RA induction (Fig. 29F). L1-A 
upregulates the expression of neuronal L1 either in presence or in absence of RA 
stimulation, suggesting the presence of positive feedback in L1 gene regulation 
(Fig.29G). In addition, L1-A treatment induces the expression of LINGO1 in the 
absence of RA stimulation (Fig. 29H). RA induced upregulation of L1 expression 
(Fig. 29G) and downregulation of LINGO1 expression (Fig. 29H) occurs in both 
peptide treated samples and controls.  
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Figure 29. Effects of L1-A and LINGO1-A on neuronal marker expression. Nestin (A), 
TUBβ3 (B), MAP2 (C), VAMP7 (D), TRKB (E), TRKB RA- (F), L1 (G) and LINGO1 (H) 
expression profile of SH-SY5Y treated with peptides compared with untreated controls. 
Data are mRNA levels normalized to the expression of the housekeeping gene S13. At 
least three independent experiments were performed in triplicate and the real time PCR 
was run twice for each sample (technical duplicate). * shows significance at p<0.05 
between peptide treated samples and control. # shows significance at p<0.05 between RA 
treated samples and their respective untreated controls. + shows significance at p<0.05 
between L1-A treated samples and LINGO1-A treated samples. 
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4.5 PROTEOME-WIDE AND PRELIMINARY MUTATIONAL 
ANALYSIS OF THE PEPTIDES 
 
We used the Ig2 domain of L1 and the Ig domain of LINGO1 as BLAST probes for 
collecting a dataset of mammals orthologues, and from the multiple alignment 
we analyzed the amino acid conservation for each position at the level of the 
peptide sequence. Such comparative analysis highlighted the seventh residue 
(Arg) in the peptide region as highly conserved. Intriguingly, it corresponds to 
Arg184 in L1CAM and its mutation to Gln is causative of the most severe CRASH 
syndrome phenotype (Jouet et al., 1994; De Angelis et al., 2002). Moreover, Zhao 
et al., showed that when replacing this Arg by Ala, the L1-A peptide is no longer 
able to bind to L1 Ig2 domain (Zhao et al., 1998). Given that the R184 position is 
likely crucial for homophilic binding and for a correct neurodevelopment as well, 
we decided to test the effect of both R184Q and R184A L1-A mutants on cell 
differentiation in our cell system. Comparison between mutant peptides, the 
wild type peptide and scrambled peptide (previously shown to have no 
neuritogenic effect) showed that R184A mutant completely lacks any 
neuritogenic effect, as values for total neurite length (Fig. 30A), number of 
neurites per cell (Fig. 30B) and percentage of neurites longer than 100 µm (Fig. 
30C) are not meaningfully different from control samples (untreated or treated 
by scrambled peptides). Concerning R184Q mutant, it retains a very low 
neuritogenic activity, as indeed the total neurite length (Fig. 30A) and the 
number of neurites per cell (Fig. 30B) are higher than control samples, but 
significantly lower that wild-type peptide treated samples. Therefore, R184 
position seems to be crucial for L1 function and we could provide the first direct 
link i.e. in the same cellular system between the role of R184 in homophilic 
binding (as demonstrated by Zhao et al, 1998) and relevance of the motif in 
neurodevelopment.  
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Figure 30. Analysis of the neuritogenic capacity of mutant L1-A peptides on SH-
SY5Y cells. Total neurite length (A), neurites per cell (B), neurites longer than 100 µm (C) 
and representative microscopy fields (D). Data represent the mean ± SEM of three 
independent experiments performed in duplicate. * shows significance at p<0.05 between 
samples treated with peptides and the control without peptides. # shows significance at 
p<0.05 between L1-A wild type and L1-A mutants/scrambled SH-SY5Y cells in (D) are 
stained with Calcein-AM. Image magnification is 32X.  
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4.6 еCNT-PLLA SCAFFOLD EFFECTS ON SH-SY5Y CELL 
ADHESION, GROWTH AND DIFFERENTIATION 
 
We electrospun the CNT-PLLA matrix into fibres of submicron size with the aim 
to better mimic the neuronal processes and the collagenous component of the 
extracellular matrix. The electrospun CNT-PLLA matrix (eCNT-PLLA) was 
deposited onto a glass coverslip to help its usage as a scaffold for cell cultures. 
Scanning electron microscopy images of the randomly oriented electrospun CNT-
PLLA fibres reveal a regular surface morphology with a diameter that range from 
300 to 600 nm (Fig. 31A-B). 
 
Next, we compared eCNT-PLLA with a scaffold made of electrospun PLLA (ePLLA) 
and with the non-electrospun CNT-PLLA scaffolds for both biocompatibility and 
neuritogenic properties. As shown in figure 32A and table 5, no differences in cell 
proliferation and cell viability were revealed when growing cells onto the three 
different scaffolds or onto the poly-L-lysine coated control wells. However, cells 
better adhere onto eCNT-PLLA (~66%) than onto ePLLA (~53%). Furthermore, the 
total neurite length is significantly increased in samples seeded onto the eCNT-
PLLA scaffolds either in presence or in absence of RA stimulation (Fig.33A). The 
number of neurites per cells is also significantly increased in samples grown onto 
Figure 31. Scanning electron microscopy images of the eCNT-PLLA scaffold 
fibres. Scale bar: A = 5 µm; B = 1 µm. 
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the eCNT-PLLA scaffolds (Fig 33B), but the analysis of the percentage of neurites 
longer than 100 µm reveals that such value is significantly lower in cells 
cultivated onto the eCNT-PLLA scaffolds compared to control and the non-
electrospun CNT-PLLA scaffolds (Fig. 33C). Therefore, the eCNT-PLLA scaffolds 
promote the formation of new short neurites. Figures 34B-E-H show the SH-SY5Y 
cells with the cytoplasmic staining calcein-AM that is particularly useful to clearly 
detect, in all their length, the neuronal processes and to visualize cells growing 
onto the non-transparent eCNT-PLLA scaffolds. Figures 34A-D-G are the bright 
field images of the corresponding portion of the scaffold and figures C-F-I the 
superimposition of the fluorescent images with the corresponding bright field 
images. As indicated by the white arrows, the newly formed neurites elongate 
following the direction of fibre orientation; this indicates that cells are influenced 
by scaffold topography and it opens up the perspective to obtain a polarized 
neurite outgrowth upon fibre alignment. 
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Figure 32. eCNT-PLLA scaffold effect on SH-SY5Y adhesion and growth. Cell 
proliferation (A) and cell distribution (B) and representative microscopy fields (C). Data 
represent the mean ± SEM of three independent experiments performed in duplicate. 
*shows significance at p<0.05 between cells seeded onto eCNT-PLLA and ePLLA scaffolds. 
Dotted bars refer to the corresponding RA treated samples. cells in (D) are stained with 
Calcein-AM. Image magnification is 32X. 
 93 
 
Table 5. Percentage of cell death relative to three independent experiments performed in 
duplicate. 
 
 
Figure 33. eCNT-PLLA scaffold effects on SH-SY5Y differentiation. Total neurite 
length (A), neurites per cell (B), neurites longer than 100 µm (C). Data represent the 
mean ± SEM of three independent experiments performed in duplicate. *shows 
significance at p<0.05 between cells seeded onto eCNT-PLLA scaffolds and control (poly-
L-lysine coated wells). #shows significance at p<0.05 between cells seeded onto eCNT-
PLLA scaffolds and ePLLA scaffolds. +shows significance at p<0.05 between cells seeded 
onto CNT-PLLA scaffolds and eCNT-PLLA/ePLLA scaffolds. Dotted bars refer to the 
corresponding RA treated samples. 
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Figure 34. SH-SY5Y cells extend neurites following the scaffold fibre orientation. 
Bright field images of the eCNT-PLLA scaffold (A, D, G), fluorescent images of RA treated 
SH-SY5Y cells stained with Calcein-AM (B, E, H), superimposition of the two (C, F, I). 
Arrows indicate neurites following the scaffold fibre orientation. Image magnification is 
32X. 
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4.7 COMBINED EFFECTS OF THE еCNT-PLLA SCAFFOLD AND 
NEURTIOGENIC PEPTIDES ON NEURONAL GROWTH AND 
DIFFERENTIATION 
 
Given that the eCNT-PLLA scaffolds resulted to be suitable for neuronal cell 
growth and they promote the formation of new neurites, cells were seeded onto 
their surfaces and treated with peptides added to culture medium to test if a 
synergistic effect between the two components occurs. The combination 
between scaffolds and peptides does not have effects on cell proliferation (Fig. 
35A); furthermore, in almost all samples seeded onto the eCNT-PLLA scaffolds, 
the total neurite length is higher than in control (poly-L-lysine coated wells), 
except for L1-A treated samples after RA stimulation (Fig. 35B). The same trend is 
observed for the number of neurites per cell (Fig. 35C), but the percentage of 
neurites longer than 100 µm is higher in control samples than in cells grown onto 
the scaffolds (Fig. 35D). The only exception concerns cells cultivated onto the 
eCNT-PLLA scaffolds and treated with the LINGO1-A peptide after RA stimulation. 
In fact, in this sample the percentage of neurites longer than 100 µm reaches the 
value of its respective control (i.e., cells seeded onto poly-L-Lysine coated wells 
and treated with LINGO1-A) (Fig. 35D). Therefore, the LINGO1-A treated samples 
onto the eCNT-PLLA scaffolds show the highest number of neurites and the 
longest neurites, hence the highest level of cell differentiation as the scaffold 
induces the formation of new neurites and LINGO1-A promotes their elongation.  
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Figure 35. Comparison between SH-SY5Y cells seeded onto the eCNT-PLLA scaffold 
and control (poly-L-lysine coated wells) when treated with 1 µM peptides in the 
absence or presence of RA. Cell proliferation (A), total neurite length (B), neurites per 
cell (C), neurites longer than 100 µm (D). Data represent the mean ± SEM of three 
independent experiments performed in duplicate. *shows significance at p<0.05 between 
samples treated with peptides and their respective untreated controls. § shows 
significance between samples growing onto eCNT-PLLA scaffold and control (poly-L-
lysine coated wells).  
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4.8 TESTING SCAFFOLDS AND PEPTIDES WITH A STEM CELL 
POPULATION 
 
We developed a nanocomposite scaffold that combine the conductive and 
nanotopographical features of multi-walled CNTs (MWCNTs) with the 
freestanding biocombatibility of poly-L-lactic acid (PLLA). Such scaffold resulted 
to support adhesion, growth and differentiation of SH-SY5Y cells without exerting 
cytotoxic effects. Furthermore, the peptides derived from L1 and LINGO1 
motives resulted to play a positive role in promoting SH-SY5Y differentiation and 
neurite extension. Therefore, after the setting up of the system with stabilized 
cell line as the SH-SY5Y cells, we decided to test our scaffolds and peptides with a 
physiological source of cells suitable for the regenerative medicine applications. 
We chose the human circulating multipotent cells (hCMCs) isolated from 
peripheral blood as they are autologous, accessible, not subjected to ethical 
restrictions and differentiable into neurons under proper conditions. All these 
characteristics make them the perfect source of stem cells exploitable for 
regenerative medicine applications. Our aim is to test the scaffolds and peptides 
with such cells in order to asses if the only features of scaffolds and peptides are 
able to induce cell differentiation toward the neuronal lineage without the use of 
growth factors that are traditionally used for the differentiation of stem cells into 
neurons. 
4.8.1 CNT-PLLA SCAFFOLD EFFECTS ON ɦCMC ADHESION, GROWTH AND 
DIFFERENTIATION 
 
We seeded hCMCs onto the CNT-PLLA scaffolds and after 5 days in culture, 
calcein-AM staining reveals these cells adhere and grow well onto the CNT-PLLA 
scaffolds, showing homogeneous spreading (Fig. 36A). No difference in cell 
proliferation was observed when seeding hCMCs onto either the scaffolds or the 
well bottoms, during the whole differentiation period (Fig. 36B). Furthermore, 
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the scaffold seems to influence cell morphology as, when seeded onto its 
surface, hCMCs show typical features of cells from the neuronal lineage like e.g. 
more fusiform cell bodies compared to the wide spread appearance of control 
cells, and neurite-like protrusions that are tipped with fan-shaped structures 
resembling growth cones (Fig. 37A). Indeed, the measurement of cell diameter 
shows that cell bodies are smaller when cells are seeded onto the CNT-PLLA 
scaffolds (Fig. 37B); in addition, more cells with a polarized appearance are 
counted onto the scaffolds with respect to controls (Fig. 37C). Finally, cells 
growing onto the scaffolds show a significant increase of total protrusion length 
and the number of protrusions per cell (Fig. 37D,E). 
 
Figure 36. CNT-PLLA scaffold effect on hCMC adhesion and growth. hCMCs stained 
with Calcein-AM. Image magnification is reported (A). Cell proliferation (B). Data 
represent the mean ± SEM of three independent experiments performed in triplicate. 
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Figure 37. Effect of the CNT-PLLA scaffolds on hCMC morphology. hCMCs stained 
with Calcein-AM (A). Mean cell diameter (B), percentage of polarized cells (C), total 
protrusion length (D), number of protrusions per cell (E). Quantification was performed 
24 hours from cell seeding. Data represent the mean ± SEM of three independent 
experiments performed in duplicate.*shows significance at p<0.05 between cells seeded 
onto CNT-PLLA scaffold and control (well bottoms). Image magnification in (A) is 32X. 
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Figure38. Effects of the CNT-PLLA scaffolds on neuronal marker expression. Nestin 
(A), TUBβ3 (B) and L1 (C) expression profile of hCMCs cultured on plates (control) and 
onto CNT-PLLA scaffolds. Data are mRNA levels normalized to the expression of the 
housekeeping gene S13. At least three independent experiments were performed in 
triplicate and the real time PCR was run twice for each sample (technical duplicate). * 
shows significance at p<0.05 between cells seeded on the CNT-PLLA scaffolds and the 
control. 
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qPCR analyses revealed a sudden change in gene expression soon after cell 
seeding onto the scaffolds. Nestin - a marker of neuronal precursors - is strongly 
upregulated after 24 hours from hCMCs seeding onto the scaffolds; then, its 
expression decreases with the maintenance in culture but it remains significantly 
higher than control cells (Fig. 38A). Neuronal L1 expression is upregulated on 
cells seeded onto the scaffolds and this is particularly evident within the first 72 
hour from seeding in the absence of RA stimulation (Fig. 38C). TUBβ3 is a marker 
specific of cells that have acquired a neuronal commitment and it is highly 
upregulated soon after cell seeding onto the scaffolds, and its expression is 
higher than control during the whole differentiation period (Fig. 38B). The 
stimulation of cells with RA does not have a positive effect on TUBβ3 expression. 
TUBβ3 was also detected at the protein level by immunofluorescence, 5 days 
from cell seeding (Fig. 39A). As shown in Fig. 39B, approximately 77% of cells 
seeded onto the scaffold in the absence of RA stimulation are TUBβ3 positive, 
while in the presence of RA stimulation only ~ 37% of cells express TUBβ3. 
Otherwise, when grown onto the well bottom, the percentage of cells positive 
for TUBβ3 is strongly reduced (~23% RA-; ~7%RA+). 
 
Figure 39. TUBβ3 expression detected by immunofluorescence. Immunofluorescence 
for TUBβ3 (green) in hCMCs after 5 days in culture. Nuclei are counterstained with 
Hoechst 33258 (blue) (A). Quantification of TUBβ3 expression considered as the 
percentage of TUBβ3 positive cells in the total amount of cell counted (B).Three 
independent experiment were performed in duplicate. * shows significance at p<0.05 
between cells seeded on the CNT-PLLA scaffolds and the control (well bottoms). # shows 
significance at p<0.05 between cells treated with RA and their respective untreated 
control. Image magnification in (A) is 20X. 
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4.8.2 L1-A AND LINGO1-A EFFECTS ON ɦCMC GROWTH AND DIFFERENTIATION 
 
We treated hCMCs with L1-A and LINGO1-A , and both peptides confirmed to be 
perfectly biocompatible as no meaningful difference was found with respect to 
untreated controls, either in the presence or absence of RA stimulation (Fig. 
40A). The two peptides seem to influence cell morphology as (i) L1-A treatment 
elicits more fusiform cell body shape (compared to the wide spread appearance 
of control cells) and outgrowth of long protrusions that resembles neurites, while 
(ii) LINGO1-A treated samples show more rounded cell bodies and long neurite-
like protrusions. Moreover, when cells are contemporarily induced with RA and 
treated with peptides, more arborized protrusions can be observed (Fig. 40B).  
 
Figure 40. Peptide effects on hCMC growth and morphology. Cell proliferation. Data 
represent the mean ± SEM of three independent experiments performed in triplicate (A). 
hCMCs stained with calcein-AM 24 hours after peptide administration, Image 
magnification is 32X (B). 
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qPCR analysis show that L1-A and LINGO1-A peptides are able to influence the 
expression of markers typical of the neuronal lineage: Nestin and TUBβ3 are 
upregulated 24 hours from peptide administration in both L1-A and LINGO1-A 
treated samples in the absence of RA stimulation (Fig. 41A,B); MAP2 is a neuron-
specific marker that resulted to be upregulated at day 3 in L1-A treated samples 
in the absence of RA stimulation and in LINGO1-A treated samples after RA 
stimulation. At day 5 we can notice an increment in the expression of this marker 
in both peptide treated samples after RA stimulation, but such incremental 
differences are not statistically significant from the control (Fig. 41C). VAMP7 - a 
vesicle associated membrane protein whose expression is high in neuronal cells - 
is crucial to the transport of lipids and proteins at the plasma membrane 
allowing neurite extension. We found that VAMP7 is upregulated in peptide 
treated samples either at day 3 and day5 in the absence of RA stimulation, while 
a strong upregulation of this marker happens in LINGO1-A treated samples after 
RA stimulation at day5 (Fig. 41D).  
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Figure 41. Peptide effects on neuronal marker expression. Nestin (A), TUBβ3 (B), 
MAP2 (C) and VAMP7 (D) expression profile of hCMCs treated with peptides and controls 
(untreated samples). Data are mRNA levels normalized to the expression of the 
housekeeping gene S13. At least three independent experiments were performed in 
triplicate and the real time PCR was run twice for each sample (technical duplicate). * 
shows significance at p<0.05 between peptide treated samples and the control. 
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4.8.3eCNT-PLLA SCAFFOLD EFFECTS ON ɦCMC ADHESION AND DIFFERENTIATION 
 
hCMCs were tested also with eCNT-PLLA scaffolds, even in this case cells are able 
to adhere and grow onto scaffold surfaces. As previously shown for the CNT-PLLA 
scaffolds, also the eCNT-PLLA scaffolds influence cell morphology as cells show 
features typical of cells of the neuronal lineages (Fig. 42A). Such cells onto the 
scaffold present a reduced diameter size and fusiform cell bodies compared to 
the wide appearance of control cells (Fig. 42B). Moreover, more polarized cells 
are counted when cells are grown onto the eCNT-PLLA scaffold (Fig. 42C); indeed 
cells show very long neurite-like protrusions and present a total protrusion 
length and a number of protrusions per cell higher than control (Fig. 42D,E). 
Interestingly, hCMCs showed high sensitivity for scaffold topography: indeed, 
from the superimposition of the Calcein-AM stained cells and the bright field 
images of the corresponding portion of the eCNT-PLLA scaffold, we can notice 
that hCMCs extend protrusions following scaffold fibre orientation as shown by 
the white arrows (Fig. 43).  
qPCR analyses, performed 24 hours after seeding, revealed the upregulation of 
Nestin, TUBβ3, MAP2 and VAMP7 neuronal markers (Fig. 44) and hence 
suggesting the neuronal differentiation program activation. 
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Figure 42. Effect of the eCNT-PLLA scaffolds on hCMC morphology.hCMCs stained 
with calcein-AM (A). Mean cell diameter (B), percentage of polarized cells (C), total 
protrusion length (D), number of protrusions per cell (E). Quantification was performed 
24 hours from cell seeding. Data represent the mean ± SEM of three independent 
experiments performed in duplicate. *shows significance at p<0.05 between cells seeded 
onto eCNT-PLLA scaffold and control (well bottoms). Image magnification in (A) is 32X. 
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Figure 43. hCMCs extend protrusions following the scaffold fibre orientation. 
Fluorescent image of hCMCs stained with Calcein-AM (A, D, G), bright field image of the 
eCNT-PLLA scaffold (B, E, H), superimposition of cell fluorescent images and scaffold 
bright field images (C, F, I). Arrows indicate protrusions following the scaffold fibre 
orientation. Image magnification is 32X. 
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Figure 44. Effects of the eCNT-PLLA scaffolds on neuronal marker expression 24h 
cell seeding. Nestin (A), TUBβ3 (B), MAP2 (C) and VAMP7 (D) expression profile of 
hCMCs cultured on plates (control) and onto eCNT-PLLA scaffolds. Data are mRNA levels 
normalized to the expression of the housekeeping gene S13. Three independent 
experiments were performed in triplicate and the real time PCR was run twice for each 
sample (technical duplicate). * shows significance at p<0.05 between cells seeded on the 
eCNT-PLLA scaffolds and the control. 
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5. DISCUSSION 
 
SH-SY5Y is a neuroblastoma cell line that shares many features with immature 
neuroblasts and hence shows characteristic of cells committed to the neuronal 
fate (Constantinescu et al., 2007). After RA treatment, several neuronal markers 
such as Nestin, VAMP7, TRKB and L1 are upregulated in SH-SY5Y cells, according 
to knowledge about RA mediated positive regulation on neuronal differentiation. 
Moreover, RA induced cell differentiation is confirmed by the increased number 
of long processes protrudring from treated cells. Therefore, SH-SY5Y cells 
represent a good model system to study neuronal differentiation in vitro. 
The synthetic peptides L1-A and LINGO1-A - designed to mimic the neural 
environment by reproducing interaction motifs involved in guidance of neuronal 
processes - were confirmed to improve neuronal differentiation and thus are 
good candidates for functionalizing neural regeneration implants. In all 
experimental conditions, both L1-A and LINGO1-A showed full biocompatibility, 
neither exerting cytotoxic effects nor influencing cell proliferation, and their 
positive effect on neuronal differentiation (with 1 M as optimal concentration) 
is sequence specific, as confirmed by control experiments with the scrambled 
peptides. Since the highest neuritogenic effects are mediated by L1-A and 
LINGO1-A (when added to the culture medium) in the presence or absence of RA 
induction, respectively, these peptides are likely to act through (at least partially) 
different pathways.  
We showed that RA promotes neuronal L1 expression; indeed, RA also induces 
the degradation of the Repressor Element-1 Silencing Transcription factor (REST) 
(Singh et al.,2011), which in turn mediates transcriptional repression of neuronal 
L1. REST is highly expressed in SH-SY5Y cells to maintain them poorly 
differentiated (Mikulak et al., 2012); therefore, RA induction promotes L1 
expression and L1-A is likely to encounter an increased number of homophilic 
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ligands on neuronal surfaces. Such binding is thought to be mimetic of the L1 
homophilic binding and hence able to stimulate neurite outgrowth through the 
activation of intracellular signaling cascades (Kenwrick et al., 2000; Loers et al., 
2005). Indeed, many neuronal differentiation genes are upregulated in RA 
induced samples after L1-A administration: Nestin and TUBβ3 expression is 
consistent with cytoskeleton rearrangements necessary for cell architecture 
changes during differentiation, VAMP7 upregulation allows the transport of 
proteins and lipids at the plasma membrane for neurite elongation, TRKB renders 
cells responsive to neurotrophins, while L1 augmentation suggests the presence 
of a positive feedback as the increase of putative ligands enhances endogenous 
L1 expression. It was previously demonstrated that L1 molecules are transported 
at the plasma membrane in VAMP7 vesicles and that L1 homophilic binding at 
the plasma membrane recruits VAMP7 vesicles for L1 recycling (Alberts et al., 
2003). Therefore, in addition to recruit VAMP7 at the plasma membrane, the L1 
homophilic binding might stimulate VAMP7 and L1 expression due to the 
involvement of these proteins in the establishment of a dynamic gradient of L1 
adhesivity necessary for neurite elongation (Kamiguchi et al., 2000).  
 
 
Figure 45. Proposed mechanism of action of L1-A peptide. (1) RA stimulation induces 
L1 endogenous molecule expression, (2) L1-A peptide binds to L1 endogenous molecules 
(3) inducing the expression of neuronal differentiation markers as TUBβ3, TRKB, VAMP7 
and L1. (4) The upregulation of VAMP7 and L1 may be of help in the establishment of a 
dynamic gradient of L1 adhesivity necessary for neurite outgrowth. 
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Otherwise, we confirmed that RA downregulates LINGO1 expression (Puttagunta 
et al., 2011) and thus, in the absence of RA, the number of LINGO1 molecules at 
the neuronal surfaces is increased. When considering similarity between L1/L1-A 
and LINGO1/LINGO1-A systems, LINGO1 might interact with LINGO1-A peptide 
stimulating neurite outgrowth as suggested by the enhancement of neuronal 
differentiation markers expression as TUBβ3, MAP2, TRKB and VAMP7. In fact, 
homophilic binding between neuronal LINGO1 and oligodendrocyte precursor 
LINGO1 occurs and leads to oligodendrocyte final differentiation inhibition 
(Jepson et al., 2012). Even though effects at neuronal level are still unclear, this 
interaction could stimulate neurite elongation, because the axon needs to grow 
properly before being myelinated. Alternatively, LINGO1-A peptide could act by 
masking LINGO1 interaction site with the other members of the 
NgR1/LINGO1/p75 complex, with neuronal NogoA or with EGFR. This in turn 
would lead to non-functional complexes formation, blocking LINGO1 inhibitory 
effect on neurite elongation. These hypotheses are supported by evidences 
according to which LINGO1 mediates homo/heterotypic interactions through its 
Ig domain (Stein et al., 2012) and that when LINGO1 is inhibited neurite 
elongation is promoted (Mi et al., 2004; Ji et al., 2006; Inoue et al., 2007; Mi et 
al., 2013; Fernandez-Enright et al., 2014). In this work, LINGO1-A treated samples 
presented the highest percentage of neurites longer than 100 m; increased 
number of such long neurites could depend on "inhibition of the inhibitory 
effect" as inhibition of repulsive forces can prevent their sprouting from parental 
neurites, favouring elongation. Moreover, the upregulation of TRKB in peptide 
treated samples suggests the possibility of TRKB signaling activation by peptides. 
Indeed, L1 homophilic binding is known to activate FGFR pathway (Kenwrick et 
al., 2000) leading to cAMP response element-binding protein (CREB) 
phosphorylation and TRKB expression (Deogracias et al., 2004; Ditlevsen et al., 
2008). Otherwise, LINGO1 is known to interact with TRKB avoiding its 
phosphorylation and hence exerting negative effects on neuronal survival and 
differentiation (Fu et al., 2010). Therefore, LINGO1-A peptide could act by 
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masking LINGO1 interaction sites with TRKB, allowing TRKB activation and the 
initiation of a signaling cascade that leads to CREB phosphorylation and TRKB 
expression (Finkbeiner et al., 1996; Deogracias et al., 2004). Even when L1-A and 
LINGO1-A were used to coat wells prior to cell seeding, their positive effect on 
neuronal differentiation was confirmed. 
 
Figure 46. Proposed mechanism of action of LINGO1-A peptide. LINGO1-A peptide 
could act by masking LINGO1 interaction site with partners and hence blocking LINGO1 
inhibitory effects on neurite outgrowth. LINGO1-A peptide might interact with LINGO1 
endogenous molecules stimulating neurite outgrowth. 
 
A proteome-wide search showed that the Arg at the seventh position in the L1-A 
and LINGO1-A peptide sequences is highly conserved in mammals and 
vertebrates; furthermore, mutations regarding this position in L1 protein (R184) 
are causative of neurological disorders (De Angelis et al., 2002) and able to 
impair the L1 homophilic binding (Zhao et al., 1998). We showed that L1-A R184A 
(Zhao mutation) peptide completely loses the neuritogenic effect when used to 
treat SH-SY5Y cells; while L1-A R184Q (CRASH mutation) peptide maintains a very 
low differentiating activity. Such results provide a unifying rationale for the role 
of the conserved motif in neuronal function and differentiation, as the same 
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position results to be crucial to both (i) adhesion, (ii) neuritogenesis and (iii) 
correct neuronal function. In fact:  
 
i. Zhao and co-workers demonstrated that the L1-A peptide is able to 
inhibit the homophilic binding between two L1 Ig2 domains and identified 
this region as the homophilic binding site. Otherwise, the L1-A R184A 
mutant is unable to inhibit such interaction (Zhao et al., 1998); 
 
ii. we showed that the L1-A peptide alone stimulates neurite outgrowth in 
SH-SY5Y cells and thus it seems to be mimetic of the entire Ig2 domain in 
promoting the homophilic binding (Scapin et al., 2014). 
 
iii. R184Q mutation is causative for the CRASH syndrome, possibly 
depending on impaired L1 homophilic binding (De Angelis et al., 2002). 
 
The low neuritogenic activity maintained by L1-A R184Q may depend on the 
compatible features of Arg and Gln (positively charged and polar); the R184A 
mutation has not been retrieved in CRASH syndrome patients and may be not 
compatible with life. Therefore, R184 position seems to be crucial for L1 
function; however, it is noteworthy that in our scrambled peptide, Arg at seventh 
position is kept and this notwithstanding, sequence randomization at other 
positions also results in activity loss. Therefore, in addition to the conserved Arg, 
further positions are crucial to the binding motif, and our own data are in 
agreement with evidence that when keeping Arg184, mutation at position 2 (Ile) 
also results in CRASH syndrome (Ruiz at al., 1995). 
The positive role played by CNTs in supporting neuronal growth and 
differentiation is suggested by recently published, excellent works (see 
Introduction). However, the limits of these systems also emerged (e.g., 
cytotoxicity of CNTs upon scaffold disaggregation). While immobilization of CNTs 
onto coverslips partially alleviate these problems (Mattson et al., 2000; Hu et al., 
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2004; Lovat et al., 2005; Malarkey et al., 2009), such a strategy is not suitable for 
regenerative medicine purposes as coverslips are not implantable. Instead, 
nanocomposite CNT-PLLA scaffolds grant (i) full biocompatibility, (ii) good 
support of cell growth and differentiation and (iii) mechanical flexibility required 
for implant purposes. Moreover, the low percentage of purified CNTs within the 
scaffold reduces both costs and cytotoxicity by residual impurities, while 
preserving the ability of CNT-based scaffolds to support neuronal growth and 
differentiation.  
Indeed, our data show that CNT-PLLA scaffolds support SH-SY5Y cell adhesion 
and differentiation better than PLLA alone. Moreover, L1-A and LINGO1-A exert 
improved neuritogenic properties when cells are cultured onto CNT-PLLA 
scaffolds and in some conditions their effect is enhanced by the CNT-PLLA 
scaffold itself. This effect is particularly evident when considering data about 
total neurite length, branch points per neurite and neurites per cell concerning 
cells cultivated onto the CNT-PLLA scaffold and treated with L1-A or LINGO1-A 
after RA induction. The combination of CNT-PLLA scaffolds, L1-A or LINGO1-A 
treatment and RA induction also promotes the formation of growth cones, likely 
because of an increased amount of cue types available for the cells in their 
environment.  
Once the CNT-PLLA scaffolds are developed, the scaffold topography was further 
improved by including fibres through the electrospinning technique. Such novel 
electrospun eCNT-PLLA scaffolds show a regular surface morphology with a 
diameter that ranges from 300 to 600 nm; therefore, scaffold fibre diameters are 
within the diameter range of axons (from 0.08 to 20 µm) (Debanne et al., 2011) 
and of collagen fibrils (from 260 to 410 nm) (Dvir et al., 2011). The eCNT-PLLA 
scaffolds showed a good level of biocompatiblility with SH-SY5Y cell cultures and 
promoted cell adhesion and differentiation better than ePLLA alone. The 
presence of CNTs (whose diameter range from 6 to 30 nm) is thought to alter the 
nanotopography of scaffold networks providing sites for cellular anchorage and 
guiding cytoskeletal extensions (Lee et al 2014). Moreover, SH-SY5Y cells resulted 
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to be very sensible to scaffold topography as they are induced to extend more 
neurites compared to control cells. The newly formed neurites are shorter than 
those from control cell neurites; however, they elongate following fibre 
orientation and this responsiveness to scaffold topography is of particular 
interest because it opens up the perspective to obtain a polarized neurite 
outgrowth upon fibre alignment. 
In addition, a synergistic effect was revealed between the eCNT-PLLA scaffold 
and LINGO1-A peptide as the scaffold induce le formation of new neurites and 
LINGO1-A promotes their elongation. This suggests a good starting point to 
develop next-generation scaffolds upon peptide functionalization.  
After setting up the biomimetic nanosystem with SH-SY5Y cells, we decided to 
test our scaffolds and peptides with a more physiological source of cells, suitable 
for regenerative medicine applications. We chose hCMCs as these adult stem 
cells can be (i) easily isolated from peripheral blood and then (ii) differentiated 
into many cell types under proper conditions; moreover, they are (iii) suitable for 
autologous transplant without implying ethical restrictions. With this work we 
showed that features of our CNT-PLLA scaffolds and biomimetic peptides are 
able to provide these cells with neuronal commitment.  
The CNT-PLLA scaffold resulted to be a good support for hCMCs adhesion and 
growth without exerting cytotoxic effects. When cultivated onto the CNT-PLLA 
scaffolds, cells show typical features of cells from the neuronal lineage, such as 
reduced size of cell bodies and polarized morphology with neurite-like 
protrusions tipped with fan-shaped structures that resemble neuronal growth 
cones. Soon after cell seeding, upregolation of typical genes from the neuronal 
lineage occurs: in particular, upregulation of Nestin indicates that cells are 
undertaking the differentiation pathway that leads to neural progenitor cells like 
neurons, oliogdendrocytes and astrocytes. However, upregulation of TUBβ3 and 
the neuronal form of L1 - that is evident 24 hours from cell seeding and 
maintained higher than control until the third (L1) and the fifth (TUBβ3) day of 
cultures - shows that some cells are acquiring a neuronal commitment. TUBβ3 is 
 116 
 
revealed at the protein level in the majority (~77 %) of cells seeded onto the 
CNT-PLLA scaffolds in the absence of RA stimulation confirming the neuronal 
commitment acquisition since TUBβ3 is a marker specific of immature and post-
mitotic neurons. Therefore the CNT-PLLA scaffolds seem to be able to confer a 
neuronal commitment to hCMCs only thanks to their own characteristics:  
 the CNT component of the scaffold - whose nanoroughness matches the 
size of the finest neuronal processes (Fabbro et al., 2013) - is indeed 
thought to mimic the neural environment topography and therefore 
favouring cell adhesion, neurite extension and differentiation toward the 
neuronal lineage; 
 CNTs are able to adsorb proteins and growth factors thanks to their 
chemical properties and enhanced surface area provided by their needle-
like shape (Chao et al., 2010; Chen al., 2013). In addition, hCMCs produce 
cytokines and growth factors capable to control their own proliferation 
and differentiation. Therefore, the CNT-PLLA scaffold could retain 
proteins and growth factors produced by hCMCs acting as a reservoir of 
elements available for cells during their growth and differentiation. 
 we previously showed that the CNT presence within the scaffold 
increases the scaffold conductivity (Scapin et al., 2014); therefore, the 
conductive properties of the scaffold could be responsible for cell 
differentiation maybe due to the formation of hybrid nanotube-cell unit 
(Mazzatenta et al., 2007). It is known in fact that electrical conductivity 
has a critical role in controlling neuronal cell growth and differentiation 
(Yamada et al., 2007; Gordon et al., 2009; Fabbro et al., 2013). 
 Cell differentiation observed onto CNT-PLLA scaffolds is likely related to 
changes in cell shape. Indeed, cells onto the scaffold have polarized 
appearance and reduced size of cell bodies. Modulating cell shape might 
play a central role in directing the fate of differentiation, because it can 
influence nucleus shape affecting nuclear matrix proteins and focal 
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adhesion complexes and thus the expression of silent genes (Kim et al., 
2012). 
 
Other studies previously reported the ability of CNT-based scaffolds to modulate 
embryonic, mesenchymal and neural stem cells commitment towards 
neurogenesis when coupled to chemical soluble factors (Jan et al., 2007; Chao et 
al., 2010; Chen et al., 2012; Kim et al., 2012). Other works show instead that such 
cells can achieve a neuronal commitment either in absence of neuronal 
stimulating conditions when CNT films (Tay et al., 2010) and CNT-collagen 
scaffolds (Chen et al., 2013; Lee et al., 2014) are used. Therefore, our study 
confirms that the CNTs features are able per se to promote stem cell 
differentiation toward the neuronal lineage and highlights that a very low 
percentage of dispersed CNTs (1%) is sufficient to improve scaffold electrical 
properities and cell differentiation. Furthermore, our scaffold combines the 
nanotopographical and electrical characteristics of CNTs with the properties of 
PLLA. This synthetic, fully biocompatible polymer is not immunogenic hence 
more suitable than animal-derived collagen for developing implantable scaffolds. 
Moreover, the dispersion of CNTs in the PLLA matrix makes the scaffold flexibility 
suitable for properly shaping and well fitting into the injured site.  
At least in our knowledge, the study presented in this thesis represents the first 
report on human adult stem cells derived from blood to be cultured onto CNT-
based scaffolds and hence highlights hCMCs as a precious source of stem cells 
exploitable for such applications. hCMCs in fact present some advantages in 
comparison to other sources of stem cells: (i) when compared to hESCs, hCMCs 
are not subjected to ethical restrictions in that representing an autologous cell 
source; (ii) unlike iPSCs, hCMCs are free from tumorigenesis risk, (iii) they can be 
isolated in larger amounts than NSCs, (iv) they can be more easily isolated and in 
a less invasive way with respect to both NSCs (brain) (Rietze et al., 2006) and 
MSCs (mainly bone marrow) (Augello et al., 2010). Therefore, such CNT-PLLA 
scaffolds both (i) support cell growth onto a low cytotoxicity environment and (ii) 
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contain the instructions necessary to drive cell neuronal differentiation. Thanks 
to these characteristics, hCMCs could be transplanted to neuron injured sites 
onto the CNT-PLLA scaffolds that would promote their differentiation without 
the addition of soluble factors that are more difficult to administrate and pattern 
in vivo (Chen et al., 2013).  
Concerning the biomimetic L1-A and LINGO1-A peptides, they were able to 
influence hCMC behaviour without altering cell proliferation. When added to 
culture medium, the peptides are able to influence cell shape as treated cell 
morphology is sharper than the wide spread appearance of control cells. 
Moreover, the two peptides induce the formation of long protrusions resembling 
neurites and stimulate the expression of neuronal cytoskeleton markers, such as 
Nestin, TUBβ3 and MAP2 that have an important role in neuronal architecture 
definition. Last but not least, the upregulation of VAMP7 is consistent with the 
enhancement of proteins and lipids transport at the plasma membrane for the 
neurite outgrowth initiation.  
Moreover, hCMCs resulted to be sensitive to scaffold topography; indeed when 
seeded onto the eCNT-PLLA scaffolds both the cell bodies and the neurite-like 
protrusions were found to be stretched out and aligned along the scaffold fibres. 
In addition, qPCR analyses showed an upregualtion of neuronal marker genes 
attesting the differentiation program activation. Considering that - for an 
effective electrical signal transfer - transplanted cells not only have to 
differentiate but also need to be synaptically connected to neural networks, the 
possibility to control both cell differentiation and polarization through scaffold 
composition and topography could be of great help to clinical applications. Such 
results suggest the possibility to covalently functionalize the scaffolds with 
peptides, in order to enrich the spectrum of differentiating cues provided by the 
scaffolds and to more finely regulate cell differentiation and their spatial 
organization.  
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6. CONCLUDING REMARKS 
 
In conclusion, we developed freestanding scaffolds that combine the 
biocompatible properties of PLLA (Yang et al., 2004) with the conductive, 
mechanical and topographical features of CNTs. Furthermore, designed L1-A and 
LINGO1-A peptides were confirmed to mediate positive effects on neuronal 
differentiation and, even though further studies are needed to clearly determine 
their mechanisms of action, they represent a promising tool for regenerative 
medicine. Indeed, replacement of recombinant proteins by biomimetic peptides 
reproducing only active motifs dramatically cuts costs, simplifies preparation and 
functionalization of scaffolds. Moreover, short peptides display increased 
stability and lower immunogenic potential with respect to entire proteins and 
protein domains (Chen et al., 2008). Our CNT-PLLA scaffold, used in combination 
with the peptides, demonstrates synergistic effects in supporting neuronal cell 
growth and differentiation and thus it is a good starting point for setting up next 
generation scaffolds upon peptide functionalization. Moreover, the hypothesis of 
LINGO1-A peptide ability to inhibit LINGO1 endogenous molecule function is of 
particular interest because a small synthetic peptide able to counteract the 
effect of inhibitory proteins is of potential wide applicability. In fact, in addition 
to being used in the development of scaffolds promoting neuronal regeneration 
after injury, it might also be of help in the treatment of some neurodegenerative 
diseases characterized by LINGO1 upregulation, like e.g. Parkinson's disease and 
Multiple Sclerosis (Inoue et al., 2007, Mi et al., 2013). Thanks to LINGO1 
restricted tissue distribution and to LINGO1-A small size that allows its 
encapsulation into nanocarriers able to overpass the emathoencephalic barrier 
(Silva et al., 2007); LINGO1-A represents an interesting starting molecule for 
developing therapeutics to cure neural dysfunctions. Our experiments with L1-A 
mutant peptides confirm the important role of the highly conserved R184 
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residue for L1 function as it is crucial at the same time to adhesion, 
neuritogenesis and correct neurodevelopment. The shaping of the CNT-PLLA 
scaffold into fibres mimicking neuronal extracellular environment results in 
enhanced cell ability to form new neurites that elongate following the scaffold 
fibre orientation. Such micro/nano-scale sensitivity of cells to the scaffold 
topography is of great interest because it opens up the perspective to obtain a 
polarized neurite outgrowth upon fibre alignment. The polarized neurite 
outgrowth is a fundamental prerequisite for neural regenerating scaffold as the 
regenerating axon needs to be properly guided towards the correct target, 
improving the formation of an effective neural network. Moreover, the 
synergistic effect shown by eCNT-PLLA scaffolds and LINGO1-A peptide suggests 
that the scaffold functionalization with LINGO1-A peptide could provide 
substrates endowed with multiple cues able to stimulate both neurite sprouting 
and their elongation and highlight the importance of nanomaterials and 
micro/nanotechnology for developing devices to control cell behaviours with a 
micro/nano-scale sensitivity. Moreover,the scaffolds and the peptides resulted 
to be suitable for hCMCs cultures and to induce their entering the neuronal 
differentiation pathway.  
Further improvements in the scaffold geometry and composition, 
functionalization with peptides and culture conditions are necessary to achieve 
the complete neuronal differentiation of cells and to control the neuron subtype 
obtained, but our system resulted to be a good starting point for setting up 
implantable scaffolds for autologous neuronal differentiation. In addition, such 
results highlight the high plasticity of hCMCs that, even if isolated from blood 
and thought to have a mesodermal origin, they are able to undergo neuronal 
differentiation, hence representing a precious source of adult stem cell with 
potential for neural tissue engineering applications. Future functional 
assessment ofsynaptic transmission and electrophysiological properties of cells 
onto the scaffolds will be of great interest. Moreover, coupling such scaffolds 
with electrical stimulation (which is readily achievable using CNT based 
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materials) can boost further analyses aimed at studying neuronal differentiation 
and has great potential in nerve injury repair as well as neuron prosthesis.  
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Carbon nanotubes (CNTs) are attractive candidates for the development of scaffolds for 
neural regeneration thanks to their ability to conduct electrical stimuli, to interface with 
cells and to mimic the neural environment (Mattson et al, J Mol Neurosci. 2000). We 
developed a freestanding nanocomposite scaffold of multi-walled CNTs in a PLLA matrix 
that combines the conductive, mechanical and topographical features of CNTs with the 
biocompatible properties of the PLLA. Such CNT-PLLA scaffold resulted to support 
growth and differentiation of human neuronal cells better than CNTs or PLLA alone. 
Moreover, to mimic guidance cues from the neural environment, we also designed 
biomimetic peptides, derived from L1 and LINGO1 proteins that are involved in neurite 
outgrowth control (Zhao et al, J Neurochem. 1998; Mi et al, Nat. Neurosci. 2004). Both 
peptides - which neither alter cell proliferation nor induce cell death - could specifically 
and positively modulate neuronal differentiation (with highest effect at 1 µM 
concentration). Furthermore, cell differentiation resulted to be synergistically improved 
by the combination of the nanocomposite scaffold and the peptides, thus suggesting a 
prototype for the development of implants for long-term neuronal growth and 
differentiation. The ongoing work is about the use of new scaffolds consisting of multi-
walled CNTs in a PLLA matrix and electrospinned into fibers. These scaffolds were shown 
to be biocompatible and to promote the formation of new neurites that extend along 
the scaffold fibers. Since cells are influenced by the scaffold topography, the orientation 
of the scaffold fibers opens up the perspective to promote a polarized neurite 
outgrowth. Moreover, the neuritogenic properties of the scaffolds are further enhanced 
when adding peptides to culture medium; thus they represent a good starting point for 
developing next generation scaffolds upon peptide functionalization. Currently, we are 
growing human circulating multipotent cells (hCMCs) onto the CNT-PLLA scaffolds to 
asses if this autologous and accessible source of stem cells is capable of neuronal 
differentiation thanks to the scaffold characteristics. Our preliminary results show that 
cells can adhere and grow onto the scaffold showing features (such as neurites and 
growth cones) typical of cells of the neuronal lineage. 
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Carbon nanotubes (CNTs) are attractive candidates for the development of 
scaffolds able to support neuronal growth and development thanks to 
their ability to conduct electrical stimuli, to interface with cells and to 
mimic the neural environment. We recently proposed a freestanding 
nanocomposite scaffold that combines the conductive and topographical 
features of functionalized multi wall carbon nanotubes (MWCNTs) with the 
biocompatible and mechanical properties of a polylactide matrix (PLLA) 
[1]. We will present here a novel morphology for the neuritogenetic 
nanocomposite substrate, based on electrospun nanofibers deposited 
onto a glass support. Details on the preparation and characterization of 
such nanofibers will be reported, together with preliminary evidences of 
polarized neurite outgrowth along the scaffold nanofibrous topography.  
 
Figure 1: Neuronal growth onto MWCNTs-PLLA electrospun nanofibers 
References: 
[1] G. Scapin, P. Salice, S. Tescari, E. Menna, V. De Filippis, and F. Filippini, 
Enhanced Neuronal Cell Differentiation Combining Biomimetic Peptides and a 
Carbon Nanotubes-Polymer Scaffold, Submitted.  
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